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Introduction 
This thesis is composed of a collection of rather divergent subjects in the 
field of clinical urodynamics. Since the entrance of the advanced urody-
namic investigation in the Department of Urology of the Sint Radboud 
University Hospital at Nijmegen in 1976, various micturition problems 
such as urinary incontinence and emptying disorders of the bladder were 
studied attentively and assessed systematically with regard to diagnosis 
and therapy. 
Several newer therapeutic modalities were analysed thoroughly, 
both clinically and urodynamically, in order to evaluate their possible 
clinical usefulness. In recent years, we have reported with regularity in 
urological journals on our insights in some aspects of urodynamic patho-
logy and our experiences with various fairly even-known therapeutic regi-
mens. Thus, this thesis will be a reflection of our continuous efforts and 
attempts to the optimum recovery of disturbed continence and micturi-
t ion. 
Most theses and textbooks dealing with urodynamic subjects have 
an introductory chapter about anatomy and neurophysiology of bladder 
and urethra. To avoid undue repetition, we have deliberately chosen to 
deviate from this current concept. However, in the following chapters, 
the most important and appropriate data regarding neuroanatomy and 
-physiology will be quoted where necessary. 
This thesis consists of four parts, representing some of the most 
intriguing problems in clinical urodynamics; particulirly the therapeutic 
possibilities in urge incontinence, emptying disorders and outflow ob-
struction, pharmacological aspects of bladder and urethra and — as an 
appendix — some considerations with regard to the anterior vaginal 
repair. 
The treatment for urge incontinence or unstable bladder is some-
times extremely unsatisfactory. Furthermore, many non-responders to 
various common medical treatments are referred to our Department. 
This very difficult situation prompted us to start open studies with less 
common drugs and more invasive treatments. Thus, the usefulness of f la-
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voxate hydrochloride, bromocriptine and indomethacin was assessed.1"3 
Nevertheless, desperate patients continue to call for rescue. Prolonged 
bladder distension has been proposed for them as a last resort4·5. 
Directly opposite to the condition of incontinence, some patients 
complain of disorders of bladder evacuation, often with huge residues. In 
obstinate forms of detrusor failure, we have started a urodynamically 
controlled study with intravesically applied prostaglandins.5 Women 
with voiding difficulties ascribed to a massive cystocele are subjected to 
a rather unusual operation whereby the vaginal vault is fixed to the sa-
cral promontory.7 Also some attention has been paid to the simple pro-
cedure of endoscopic bladder neck incision for relief of outflow obstruc-
tion and residual urine. Indications, results and complications have been 
compared in both males and females8·9. 
Increasingly, progress has been made in understanding the influ-
ence of drugs on the lower urinary tract. Particularly, urethral relaxation 
caused by alpha-blockers has proved to be of great clinical value especi-
ally in neurogenic bladders. Somewhat accidentally, we have found out 
that prazosin, a new antihypertensive agent, has properties enabling 
sphincter insufficiency to be induced.10 Other known antihypertensive 
drugs such as guanethidine and alpha-methyldopa have been studied with 
particular reference to urethral tone and continence.11 In our further 
search for better drugs in the treatment of the unstable bladder, a sero-
tonin antagonist has been evaluated urodynamically, since serotonin re-
ceptors within the bladder muscle should have an inhibitory action.12 
For many years we have been confronted from time to time with 
possibly disastrous impairment of bladder and urethral function after an-
terior vaginal surgery. Such experiences are analysed in the last chapter, 
which reflects the views of a urologist on a gynaecological procedure.13 
In the closing remarks, the papers will be provided where necessary 
with supplementary comment. Special attention will be paid to the most 
recent literature which appeared after publication of some of our articles. 
With reference to each part of this thesis, general conclusions will be 
drawn with up to date insights, which we consider of importance for 
urologica! practice. 
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Statement of the problems 
In the following chapters, we will report on our experiences with some 
common clinical urodynamic problems. The following questions will be 
analysed and answered as far as possible. 
1. What is the value of some medicines in the treatment of motor urge 
incontinence? 
2. Is prolonged bladder distension a valuable alternative procedure for 
patients with urge incontinence who have not responded to medical 
treatment? 
3. Are bladder instillations with prostaglandins able to restore bladder 
evacuation? 
4. What are the results of fixation of the vaginal vault to the sacral pro-
montory in cases of disturbed micturition due to massive bladder pro-
lapse? 
5. What are the indications for and results of bladder neck incision (in 
males and in females) for relief of obstructed micturition? 
6. Is there any relation between the use of antihypertensive drugs and 
the occurrence of urinary incontinence? 
7. What is the influence of a serotonin antagonist on the dynamics of the 
lower urinary tract? 
8. What kind of voiding problems might occur following an anterior va-
ginal repair? 
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Parti 
Therapeutic aspects of the unstable 
bladder 
Chapter I 
Flavoxate Hydrochloride in the 
Treatment of Detrusor Instability 
K.P.J. Delaere, H.G.E. Michiels, 
F.M.J. Debruyne and W.A. Moonen 
Department of Urology, St Radboud University Hospital, Nijmegen 
ABSTRACT 
42 patients with 'unstable bladder' were treated with flavoxate hydro-
chloride. A previous treatment with parasympathicolytic drugs (propan-
theline bromide and/or emepromum bromide) was unsuccessful. The in-
stability of the detrusor was proven by a urodynamic investigation Fla-
voxate hydrochloride is a papaverme-like smooth muscle relaxant. The 
results and the complications of the treatment are discussed. 
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A urodynamic study carried out in patients suffering from micturition 
complaints such as urgency, frequency, urge incontinence, nocturnal 
enuresis and nocturia, often reveals detrusor instability. If, however, the 
cystometrogram shows a completely stable detrusor while the urge and 
frequency symptoms predominate, this is described as sensory urgency. 
Sensory urgency can occur in association with cystitis, metaplasia of the 
trigone or as a rest symptom of an anterior colporrhaphy. We are dealing 
with motor urgency—motor urge incontinence — when the cystometro-
gram shows uninhibited detrusor contractions. 
The treatment of detrusor instability or an unstable bladder some-
times brings problems since the etiology is not usually known. In some 
cases the uninhibited detrusor contractions are the result of a urological 
disorder (e.g., outflow obstruction, urethrovesical irritation) or a neuro-
logical problem. These cases demand causal therapy. When an extensive 
urological and neurological investigation is however negative, then the 
detrusor instability is idiopathic or primary. In that case the treatment 
can only be symptomatic. 
The most conservative treatment is the administration of anticho-
linergics (propantheline bromide, emepronium bromide) which attempt 
to inhibit the hyperactive reflex arc (detrusor — sacral micturition center) 
or psychotropic drugs aimed at breaking the reflex arc at the medulla-
cortical level (Michiels et al., 1976). 
However, the results of this type of medical therapy are often dis-
appointing. Perhaps this is because the uninhibited detrusor contractions 
in certain cases are the result of a primary muscular hyperactivity rather 
than a disturbed cholinergic transmission. 
With this in mind, we used flavoxate hydrochloride (Urispas) to 
treat 42 patients who had previously been treated unsuccessfully with 
propantheline bromide and/or emepronium bromide;some had also had 
psychotropic drugs and bladder distension. Flavoxate hydrochloride is a 
smooth muscle relaxant with pharmacological characteristics comparable 
to those of papaverine (Setnikar et al., 1960; Pedersen et al., 1972). 
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There are no anticholinergic side effects (Pedersen et al., 1972), however, 
it exhibits a weak anticholinergic activity in animal experiments (Bradley 
and Cazort, 1970). Different investigators have administered it with suc-
cess as a urinary antispasmodic and analgetic (Bradley and Cazort, 1970; 
Servadio, 1974; Baert, 1975). 
Flavoxate appears to be even more effective than emepronium 
bromide in thetreatment of frequency, urge and incontinence (Stanton, 
1973). At the same time it seems that flavoxate is much less likely to 
cause side effects in comparison with those of the parasympatholytic 
drugs. A comparative study of flavoxate and propantheline bromide re-
vealed that the preparations were equally active (Kohier and Morale, 
1968). The symptoms urgency and frequency were more favorably in-
fluenced by administration of flavoxate (Bradley and Cazort, 1970; 
Herbst, 1970). 
Significant urine retention — an occasional side effect of anticho-
linergics — did not occur or was present to a lesser degree in patients 
treated with flavoxate than with emepronium bromide (Stanton, 1973). 
As a urinary analgesic, flavoxate is more active than phenazopyridine 
(Pyridium) (Gould, 1975). 
When drug therapy is not effective or involves undesirable side ef-
fects, then one must resort to more aggressive methods of treatment— 
such as bladder distension (Dunn et al., 1974;Whitfield and Mayo, 1975; 
Michiels et al., 1976),sacral neurectomy (Torrens and Griffith, 1974) or 
transection of the bladder (Essenhigh and Yeates, 1973). 
PATIENTS AND METHODS 
42 patients (9 males and 33 females) took part in this investigation. 
Their ages ranged from 8 to 70 years (average 33 years). 
Urological investigation (clinical examination, urine and blood 
tests, IVU and cystogram) was always negative, the neurological study 
showed that 6 patients had spina bifida, 2 had an upper motor neuron 
lesion and 1 had amyotrophic lateral sclerosis. Another patient exhibited 
parkinsonism. The remaining 32 patients had negative neurological re-
sults. All patients had previously been treated over varying periods with 
propantheline bromide and/or emepronium bromide, but without result. 
4 of these 32 patients had also undergone bladder distension. A 
full urodynamic investigation was carried out of each patient. The con-
tinuous filling cystometrogram was carried out as follows: 
Two catheters were inserted into the bladder via the urethra; a f i l -
ling catheter 12F and a pressure catheter 6F. There was also a catheter 
filled with water inserted into the rectum. 
The electronic difference between the total bladder pressure and 
rectal pressure gives the intrinsic bladder pressure (or detrusor pressure) 
and is recorded on a third channel. A bipolar EMG needle is used for the 
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electromyogram of the external anal sphincter. This is given on another 
channel. The bladder is filled with distilled water at room temperature at 
a constant inflation rate of 50 ml/min. After the bladder has been filled 
with around 200 ml the patient straightens up. During the filling cysto-
metrogram the patient is asked to cough repeatedly, since coughing can 
provoke an unstable detrusor contraction. 
When the patient indicates a strong urge, the filling catheter is re­
moved and he is set beside a flowmeter. During the micturating cystome-
trogram the total bladder pressure, the rectal pressure, the intrinsic blad­
der pressure, the flow and the electromyogram are all recorded simulta­
neously on different channels. 
A urethral pressure profile —according to Brown and Wickham's 
method (1969) — was also carried out to see if there were any associated 
weakness of the sphincter. A 8F catheter, with four side holes at б cm 
from the closed catheter top, was introduced into the bladder and with­
drawn mechanically at a rate of 1 mm/sec. The catheter was perfused 
with 2 ml/min. 
At the same time as the pressure profile, the rectal pressure was 
measured and an electromyogram was made of the external anal sphinc­
ter. The profile was carried out while the patient was at rest, coughing, 
tightening of the pelvic floor, both with a full and an empty bladder — 
and in a lying and standing position. 
The flavoxate dosage depends on the age of the patient; as a rule 
it is 400-800 mg/day, taken orally. We determined these daily doses on 
the basis of data we derived from the results of various double-blind 
trials where flavoxate appeared to be active in adults at dosages of 600-
800 mg/day. We give children 400 mg flavoxate/day. 
With reference to observations in the literature that daily dosages 
of up to 1,500 mg can be administered without appreciable side effects 
(Pedersen et al., 1972), we increased the dosage in 4 of our patients to 
1,200 mg flavoxate/day. Increasing the dosage to 1,200 mg/day did not 
lead to any more side effects than with 800 mg/day. We were able to 
follow up the patients who were treated with flavoxate, over a period of 
2-18 months. 
RESULTS 
Table I gives an analysis of the urinary complaints. The subjective im­
provement in these complaints was assessed as good (disappearance of 
all the symptoms), fair or no improvement. In 5 of the patients all the 
complaints disappeared completely and in 11 they were decreased. Side 
effects occurred far less often with flavoxate than with anticholinergics. 
In 25 patients the therapy was discontinued because of lack of re­
sults. One patient withdrew herself from treatment because of severe side 
effects (general malaise). 
19 
Table I. Results with flavoxate hydrochloride (n = 42) 
Symptom 
Urge 
Frequency 
Urge incontinence 
Nocturnal enuresis 
Nocturia 
Number 
39 
27 
33 
17 
18 
Result 
good 
η 
10 
8 
6 
2 
4 
% 
26 
30 
18 
12 
22 
fair 
η 
11 
7 
11 
7 
5 
Table I I . Side effects with flavoxate hydrochloride (n = 
Side effects 
Increased retention 
Nausea 
Headache 
Vomit ing 
General malaise 
Number 
2 
2 
2 
1 
1 
% 
5 
5 
5 
2 
2 
% 
28 
26 
33 
41 
28 
42) 
no 
η 
18 
12 
16 
8 
9 
improvement 
% 
46 
44 
49 
47 
50 
Table II gives the side effects. These were mainly transitory and 
did not lead to discontinuation of the treatment — except in the case of 
the patient who withdrew herself because of general malaise. 
CONCLUSION 
A selected group of 42 patients with a urodynamically proven detrusor 
instability which had been previously treated with anticholinergics and/ 
or bladder distension without success, were treated with flavoxate hy­
drochloride (Urispas). 
5 patients were completely relieved of all the complaints; in 11 
the symptoms improved. Urgency and frequency showed the most favor­
able reaction to the treatment, nocturnal enuresis the least. 
In view of the selected patient material (unstable bladders not 
reacting to anticholinergics/bladder distension) the generally better re­
sults to be found in the literature (50-80%) are not comparable with the 
results of our trial. We are convinced that if flavoxate had been the first 
choice preparation we would also have obtained better results. 
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Chapter II 
Has Bromocriptine a Place in the 
Treatment of the Unstable Bladder? 
K.P.J. Delaere, F.M.J. Debruyne and 
W.A. Moonen 
Department of Urology, St Radboud University Hospital, Nijmegen, 
The Netherlands 
SUMMARY 
A clinical study of bromocriptine in the treatment of 18 patients with an 
unstable bladder is reported. All patients had previously received drug 
therapy and/or vesical distension, without success. Ten of the 18 patients 
had side-effects, and 2 of these did not complete the study. Only 2 pa-
tients noted moderate improvement in their urinary symptoms. Bromo-
criptine appears to be of little value in the treatment of the unstable 
bladder. 
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The cystometrogram of patients suffering from urgency, frequency, noc-
turia, nocturnal enuresis or urge incontinence often reveals uninhibited 
bladder contractions. Some of this detrusor instability may bea conse-
quence of a urological disease, such as an infra-vesical obstruction in the 
male (Turner-Warwick et al., 1973) or vesical irritation due to urinary 
infection. Sometimes the symptoms of detrusor instability may be the 
result of an overt neurological disorder. However, in most patients uro-
logical and neurological examination reveal no abnormality. We think 
that this primary or idiopathic instability is caused by a hyperactive re-
flex arc between the receptor organ (the bladder), the sacral micturition 
centre and the higher central nervous system (Michiels et al., 1976). 
Conventional therapeutic modalities aim at influencing this reflex 
arc at 1 or more levels. Drugs remain the first choice of treatment and 
the most common are parasympathicolytics and/or/3-sympathicomime-
tics. If these are unsuccessful we advise a smooth muscle relaxant (flavo-
xate hydrochloride) since in these cases the instability may be due to 
primary muscular hyperactivity rather than to faulty cholinergic trans-
mission (Delaere et al., 1977). Since some success has been reported 
using prolonged bladder distension (Dunnef al., 1974) it has been used 
in patients not responding to drugs; our overall success rate has been 30% 
(Michiels et al., 1976). Some cases were submitted to a transection of 
the bladder (Turner-Warwick and Ashken, 1967; Essenhigh and Yeates, 
1973), or to a cystolysis, with either limited or no success. 
Recently, Farrar and Osborne (1976) reported some success with 
the use of bromocriptine (2-bromo-a-ergocryptine), a prolactin antago-
nist, in the management of the unstable bladder. We report our expe-
rience with this drug in patients in whom 1 or more of the above men-
tioned therapies failed to produce a satisfactory improvement. 
25 
PATIENTS AND METHODS 
Six male (aged 24 to 67 years) and 12 female (aged 18 to 69 years) pa-
tients have been treated with bromocriptine. All patients presented with 
a history of urgency, frequency, nocturia, urge incontinence and/or noc-
turnal enuresis. 
In the males outflow obstruction as a cause of detrusor instability 
was excluded. Four patients had a neurological disorder: 1 female had a 
spastic tetraplegia, 1 male had an upper motor neuron lesion and 2 
males had been operated upon for a meningomyelocele. In the remaining 
14 patients neurological and urologica! examination was negative. All 
patients had previously received drug therapy (propantheline bromide, 
emepronium bromide, Imipramine or flavoxate hydrochloride) without 
success. Four patients were also treated with prolonged bladder disten-
sion and 1 patient underwent a transection of the bladder, without relief 
of their symptoms. 
All patients had undergone a continuous filling cystometrogram 
(filling rate of 50 ml per min) and a pressure/flow analysis and each 
patient demonstrated unstable detrusor contractions. 
Treatment with bromocriptine lasted for 6 weeks. Bromocriptine 
was administered by slowly increasing the dose in order to avoid the ini-
tial side-effects. For the first 3 days each patient received 1 capsule con-4 
taining 2.5 mg of bromocriptine. Thereafter the dose consisted of 2.5 mg 
twice a day. The patients were informed of the possible side-effects of 
the drug. The drug was taken with meals. 
RESULTS 
Sixteen of the 18 patients completed the treatment. One female stopped 
the treatment after 7 days and another after 14 days because of distres-
sing lethargy and vomiting. Side-effects in 8 patients were transient and 
consisted of nausea, headache, lethargy, vomiting, constipation and 
dizziness (Table 1). 
Table 1. Side-effects of Bromocriptine (10 of the 18 Patients) 
Side-effects No. of patients 
Nausea 8 
Vomit ing 3 
Lethargy 2 
Dizziness 2 
Constipation 2 
Headache 1 
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Only 2 of the 16 patients who completed the study noted sympto-
matic improvement, which was attested as moderate (Table 2). Both pa-
tients continued to have an unstable pattern on cystometry, though the 
functional bladder capacity was slightly increased in 1 patient. Only 1 
patient of the 2 who benefited agreed to further treatment. 
Table 2. Symptoms of 18 Patients with an Unstable Bladder and Results with 
Bromocriptine 
Symptoms No. of patients Moderate improve-
ment on bromo-
criptine 
Urgency 15 1 
Frequency 15 2 
Urge incontinence 14 2 
Nocturnal enuresis 13 1 
Nocturia 10 0 
DISCUSSION 
Animal experiments have suggested that the pituitary hormone prolactin 
plays an important part in controlling growth of the prostate (Scott, 
1952). Further investigations (Grayhack et al., 1955; Asano, 1965) 
showed that prolactin potentiated the effect of testosterone on prostate 
growth in rats. The administration of antiovine prolactin serum could 
reduce prostatic size in rabbits (Asano et al., 1971). Recently, the effect 
of bromocriptine as a prolactin antagonist was studied in human benign 
prostatic hypertrophy (Farrar and Pryor, 1976). It was noted that the 
symptoms of frequency, urgency, nocturia and urge incontinence, most 
commonly due to detrusor instability caused by the outflow tract ob-
struction, improved markedly. However, there was no significant in-
crease in flow rate. Thus the effect of bromocriptine seemed to be due 
to an effect on the detrusor rather than to relief of the outflow obstruc-
tion. This prompted Farrar and Osborne (1976) to carry out a double 
blind trial to assess its effectiveness in patients with an unstable bladder 
in the absence of outflow obstruction. Their results were encouraging, in 
spite of the fact that many of their patients failed to respond to other 
treatments and only 5 of the 24 patients developed side-effects. 
The results of our study are disappointing. There was a moderate 
improvement in only 2 of the 16 patients who completed the trial. In 
view of these results and also the incidence of serious side-effects, we 
have stopped using the drug. It may be relevant that our patients with 
detrusor instability consisted of a selected group not responding to other 
forms of treatment such as drugs and prolonged bladder distension. 
It is known that bromocriptine, a semi-synthetic ergot alkaloid, 
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inhibits prolactin secretion (Pasteéis et al., 1971). It use in the treatment 
of hyperprolactinaemic amenorrhoea and in the inhibition of puerperal 
lactation is well known. The properties of bromocriptine as a long acting 
central dopamine receptor stimulant (Corrodi et al., 1973; Thorner, 
1975) are probably the basis of its action in Parkinsonism. 
The possible effect of bromocriptine on the unstable bladder 
might be due to a stimulating effect on the central nervous system. 
However, an antagonistic action of acetylcholine such as demonstrated 
by Janssen and Jageneau (1957), where bromocriptine reduced gastro-
intestinal propulsion, suggests a different mechanism. 
It is concluded that, in spite of the possible hypothetical effect of 
bromocriptine on bladder function, this drug appears to be of little value 
in the treatment of the unstable bladder. 
REFERENCES 
Asano, M. (1965). Basic experimental studies of the pituitary prolactin-
prostate interrelationships. Journal of Urology, 93, 87-93. 
Asano, M., Kanzaki, S., Sekiguchi, E. and Tasaka, T. (1971). Inhibition 
of prostatic growth in rabbits with antiovine prolactin serum. Jour-
nal of Urology, 106, 248-252. 
Corrodi, H., Fuxe, К., Hökfelt, T., Lidbrink, P. and Ungerstedt, U. 
(1973). Effect of ergot drugs on central cathecholamine neurons. 
Journal of Pharmacy and Pharmacology, 25, 409-411. 
Delaere, K.P.J., Michiels, H.G.E., Debruyne, F.M.J, and Moonen, W.A. 
(1977). Flavoxate hydrochloride in the treatment of detrusor in-
stability. Urologia Internationalis (In press). 
Dunn, M., Smith, J.C. and Ardran, G.M. (1974). Prolonged bladder dis-
tension as a treatment of urgency and urge incontinence. British 
Journal of Urology, 46, 645-652. 
Essenhigh, D.M. and Yeates, W.K. (1973). Transection of the bladder 
with particular reference to enuresis. British Journal of Urology, 
45, 299-305. 
Farrar, D.J. and Osborne, J.L. (1976). The use of bromocriptine in the 
treatment of the unstable bladder. British Journal of Urology, 48, 
235-238. 
Farrar, D.J. and Pryor, J.S. (1976). The effect of bromocriptine in pa-
tients with benign prostatic hypertrophy. British Journal of Uro-
logy, 48, 73-75. 
Grayhack, J.T., Bunce, P.L., Kearns, J.W. and Scott, W.W. (1955). In-
fluence of the pituitary on prostatic response to androgen in the 
rat. Bulletin of the Johns Hopkins Hospital, 96, 154-163. 
Janssen, P.A.J, and Jageneau, A.H. (1975). A new series of potent anal-
gesics. Part. \.Journal ofPharmacy andPharmacology, 9,381-400. 
Michiels, H.G.E., Delaere, K.P.J., Debruyne, F.M.J, and Moonen, W.A. 
28 
(1976). Treatment of non-neurogen'ic unstable bladder by pro-
longed bladder distension. Paper read atthefr* International Con-
tinence Society Meeting, Antwerp. Urologia Internationalis (In 
press). 
Pasteéis, J.L., Danguy, Α., Frerotte. M. and Ectors, F. (1971). Inhibition 
de la sécrétion de prolactine par l'ergocornine et la 2-Br-a-ergo-
kryptine: action directe sur l'hypophyse en culture. Annales 
d'Endocrinologie (Paris), 32, 188-192. 
Scott, W.W. (1952). Endocrine management of disseminated prostatic 
cancer, including bilateral adrenalectomy and hypophysectomy. 
Transactions of the American Association of Genito-Urinary Sur-
geons, 44, 101-104. 
Thorner, M.O. (1975). Dopamine is an important neurotransmitter in 
the autonomic nervous system. Lancet, 1, 662-664. 
Turner-Warwick, R.T. and Ashken, M.H. (1967). The functional results 
of partial, subtotal and total cystoplasty with special reference to 
ureterocaecocystoplasty,selective sphincterotomy and cystocysto-
plasty. British Journal of Urology, 39, 3-12. 
Turner-Warwick, R.T., Whiteside, C.G., Worth, P.H.L, Milroy, E.J.G. 
and Bates, C.P. (1973). A urodynamic view of the clinical pro-
blems associated with bladder neck dysfunction and its treatment 
by endoscopic incision and transtrigonal posterior prostatectomy. 
British Journal of Urology, 45, 44-59. 
29 

Chapter III 
The Use of Indomethacin in the 
Treatment of Idiopathic Bladder 
Instability 
K.P.J. Delaere, F.M.J. Debruyne, W.A. Moonen 
Department of Urology, St Radboud University Hospital, Nijmegen, 
The Netherlands 
ABSTRACT 
55 patients suffering from voiding disorders associated with primary de­
trusor instability, have been treated with indomethacin. All patients had 
remained resistant to conventional medical treatment. 7 patients did not 
complete the clinical trial. After a б-week trial period, the patients' 
symptom changes and side-effects were assessed. Only 17% of the pa­
tients who completed the trial benefited from the treatment. Side-effects 
were encountered in 42% of the cases. 
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Uncontrol led or unstable bladder contractions may cause complaints 
such as urgency, frequency, urge incontinence, nocturia and nocturnal 
enuresis The etiology of this lower urinary tract dysfunction is mostly 
unknown (primary or idiopathic). Often an unstable bladder may have a 
neurologic or urologie basis (table I). 
Table I. Etiology of bladder instability 
1 Primary or idiopathic (psychosomatic') 
2 Urologica! disease 
Urinary tract infection, inflammation 
Infra-vesical obstruction m the male 
3 Neurological disease 
Detrusor instabil ity remains one of the mam unsolved therapeutic 
problems m clinical urodynamics. Medical therapy is usually the first 
choice of treatment and the most common drugs are propantheline bro-
mide, emepromum bromide, flavoxate hydrochloride and Imipramine 
The results are often poor, and unwanted side-effects may appear. Since 
m the group of ' idiopathic unstable bladders', emotive and psychological 
factors play an important role m the genesis of the bladder dysfunct ion, 
some patients may prof i t f rom certain forms of autosuggestion and bio-
feedback [Cardozo et al., 1978]. Incases m which the conventional forms 
of psychomedical treatment are ineffective, and the symptoms of ur-
gency and urge incontinence are suff iciently severe, one might t r y some 
more aggressive therapeutic modalities such as prolonged bladder disten-
sion After extensive experience wi th this technique, we do not recom-
med its further use [Delaere et al., 1980]. We doubt whether other treat-
ments like transection of the bladder, selective sacral neurectomy, mul t i -
ple detrusor myo tomy and cystolysis would solve the problem of the 
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unstable bladder In fact, for this reason one is still t ry ing other phar-
macologic agents for their efficiency m bladder instabil i ty. 
Parasympathicolytic drugs interfere wi th the cholinergic transmis-
sion, among others by competing wi th acetylcholine at the postganglionic 
receptors. Since it is suggested that not only acetylcholine, but also 
prostaglandins are necessary for the maintenance of vesical tone and ac-
t iv i ty [Abrams and Fenely, 1975, Bul t i tude et al , 1976], it might be 
plausiblethat prostaglandin antagonists or prostaglandin synthetase inhi-
bitors should dimmish abnormal bladder contract i l i ty This had led to 
suggestions that indomethacm.an ant i- inf lammatory agent which inhibits 
the synthesis of prostaglandins, might be useful m treatmg bladder insta-
bi l i ty . Cardozo and Stanton [1978] have reported on the therapeutic 
u t i l i ty of mdomethacm m a preliminary study. They concluded that 
mdomethacm produced improvement m both diurnal and nocturnal fre-
quency of mictur i t ion and therefore warranted further evaluation. We 
report our findings w i th mdomethacm m patients m whom other thera-
peutic agents failed te produce a satisfactory improvement, in order to 
further assess its role m treating unstable bladders. 
PATIENTS A N D METHODS 
55 patients, 10 men and 45 women (aged 16-65years), entered a clinical 
study of mdomethacm. A l l patients presented w i th a history of urgency, 
frequency, nocturia and urge incontinence and/or nocturnal enuresis. On 
cystometrogram (f i l l ing rate of 50 ml /mm) all patients demonstrated un-
mhibitable detrusor contractions. Urinary infection and out f low obstruc-
t ion (evaluated among others by a pressure/flow analysis of mictur i t ion) 
as a cause of unstable bladder could be excluded. Neurological examina-
t ion could not reveal any abnormali ty The patients had previously re-
ceived drug therapy (propantheline bromide, emepromum bromide or 
flavoxate hydrochloride) wi thout success. Treatment wi th mdomethacm 
lasted for 6 weeks Patients were instructed to take their drug wi th food 
m order to avoid undesirable side-effects. The dose consisted of 50 mg 
twice a day. 
RESULTS 
48 of the initial 55 patients completed the treatment; 7 patients (13%) 
had to stop treatment because of intolerable side-effects. In tota l , 42% 
of the patients had side-effects (table I I ) . 
A t the end of the 6-week period, the subjective results have been 
assessed by means of the symptomatic changes occurring during the t r ia l . 
Symptomatic assessment was attested as cured, improved, unchanged 
and worse (table I I I ) . Patients were considered to be subjectively cured 
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if they no longer complained of urgency, f requency, nocturia or incon-
tinence. When these mictur i t ion complaints were reduced by about 50%, 
the result was symptomat ical ly attested as improved. In general, it can 
be said that only 17% of the patients benefited more or less by the the-
rapy (table I V ) . 
Table I I . Side-effects of indomethacin 
Side-effect Number of patients % 
Heartburn 
Headache 
Dizziness 
Nausea 
Lethargy 
Total 
13 
5 
6 
6 
2 
23 of the 55 patients 
24 
9 
11 
11 
4 
42 
Table I I I . Symptomatic assessment before and after treatment with Indomethacin 
In 48 patients 
Symptoms 
Urgency 
Urge inconti 
Frequency 
Nocturia 
¡nence 
Nocturnal enuresis 
Prior to 
treatment 
45 
40 
42 
30 
29 
After treatment 
cured 
η 
2 
1 
2 
1 
1 
% 
4 
2.5 
5 
3 
3.5 
Improved 
η % 
5 
4 
5 
2 
5 
11 
10 
12 
7 
17 
unci 
η 
38 
35 
34 
27 
22 
langed 
% 
85 
87.5 
81 
90 
76 
worse 
η % 
— 
— 
1 2 
— — 
1 3.5 
Table IV. Subjective results with indomethacin in 48 patients with an unstable 
bladder 
Result Number of patients % 
Cured 
Improved 
Unchanged 
Worse 
2 
6 
39 
1 
13] 1 7 
81 
2 
Total 48 100 
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DISCUSSION 
The possible mechanism of action of indomethacin on bladder funct ion, 
might be that indomethacin, as a prostaglandin synthetase inhibi tor, 
should reduce the contracti le effects of prostaglandins on bladder mus-
cle. In spite of this hypothetical effect of indomethacin, our results in 
treating patients wi th bladder instabil ity are rather disappointing. Never-
theless, it is important to stress that the patients who entered our t r ia l , 
consisted of a selected group not responding to the conventional medical 
treatments. Perhaps, if indomethacin had been the first choice prepara-
t ion , we would have obtained better results. 
We know it is no easy matter to evaluate the therapeutic u t i l i t y of 
pharmacologic agents in the treatment of unstable bladder. Firstly, we 
have mainly the patients' subjective data to go by. Secondly, we have 
no clear idea yet of the natural history of the unstable bladder. It is 
known that bladder instabil i ty is changeable and some patients may get 
better on their own, whi le others may benefit f rom supportive psycho-
therapy. Al though in our study no posttreatment cystometric evalua-
tions were performed and controls have not been provided, we th ink 
that the data obtained suggest that indomethacin appears to be of l i t t le 
value in the treatment of the unstable bladder. Moreover, taking into 
consideration the high incidence of side-effects, we do not recommend 
this therapy to be pursued further. 
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Chapter IV 
Treatment of Non-neurogenic 
Unstable Bladder by Prolonged 
Bladder Distension (initial 
experiences) 
H.G.E. Michiels, K.P.J. Delaere, 
F.M.J. Debruyne and W.A. Moonen 
Department of Urology, St Radboud Ziekenhuis, Nijmegen 
ABSTRACT 
22 patients with urodynamically demonstrated unstable bladder, in 
whom urological and neurological examination was negative, were 
treated by prolonged bladder distension. Treatment with parasympatho­
lytic drugs was unsuccessful in all these cases. A review is given of the 
method, complications and results, clinical as well as urodynamic. The 
procedure was successful in б of the 22 cases. 
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Symptoms of urgency and incontinence can be the result of uninhibited 
unstable bladder contractions. Some of these instabilities can be the re­
sult of urological (irritation, intravesical obstruction) or neurological di­
seases. In these cases, treatment must be causative. However, in a large 
group of patients extensive urological and neurological examination can­
not reveal any abnormality. In these cases, treatment can only be symp­
tomatic. 
It is our opinion that instability is caused by a hyperactive reflex 
arc. This reflex arc can be influenced in one or more ways, for instance 
by trying to interfere with it or to interrupt it. This can be done at four 
levels, as shown in figure 1: (A) influence on the afferent impulses 
(extero- and proprioceptors, afferent nerves); (B) influence on the cen­
ters (medullary or cortical); (C) influence on the efferent impulses, and 
(D) influence on the receptor organ (the bladder). 
Figure 1. Therapeutic modalities. A = interference with afferent nerves; В = inter­
ference with lower and higher centers; С = interference with efferent nerves; D = 
influence on receptor organ. 
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Different treatments have been tr ied in recent years to interrupt 
this hyperactive reflex arc. Table I shows the level at which these various 
therapeutic modalities are supposed t o interfere wi th the reflex arc. 
As could be expected none of these methods proved to be the 
ideal one, all having successes and failures. 
Table I. Therapeutic modalities 
Urethral dilatation or urethrotomia interna (OTIS) A 
Cauterization of trigone (electrical) A 
Cauterization of vesical mucosa (chemical) A 
Neurotomies and blocks А,С 
Psychotherapy and psychopharmaca В 
Parasympatholytic drugs С 
Cystolysis A,C 
Transection of the bladder c.q. myotomy A?C?D 
Bladder distension A?C?D? 
When a patient presents w i t h symptoms related t o bladder instabi­
l i ty, it is necessary t o exclude all urological and neurological disorders. 
When these have been excluded, symptomatic therapy wi l l be in the first 
place as conservative as possible. Therefore the use of parasympatholytic 
drugs is so c o m m o n . However, not all patients respond well t o this the­
rapy. For the nonresponders we have to resort to more aggressive mea­
sures. Of the different therapeutic modalities, we chose prolonged blad­
der distension as described by Dunn (1974). We report here the results 
of 22 patients treated by this method. 
PATIENTS A N D METHODS 
22 patients in whom urodynamic investigation showed the existence of 
an unstable detrusor were treated by prolonged bladder distension. A l l 
of these patients had received a selection of different drugs (propanthe­
line bromide, emepronium bromide, flavoxate hydrochloride) for several 
months t o several years. None of them showed any improvement. Neuro­
logical and urological investigation was negative. 
Distension was performed under general or epidural anesthesia. 
The choice of anesthesia depended on medical and/or psychological fac­
tors (some patients preferred general anesthesia). (Table I I). 
A f t e r emptying the bladder, a Couvelaire catheter on which a 
condom wastied was introduced into the bladder. The catheter was con­
nected t o a plastic bag of sterile saline solut ion, on which pressure could 
be exerted. A Lewis cystometer measured the pressure in the closed sy­
stem. 
The bladder was then f i l led unti l a pressure between the systolic 
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blood pressure and half the sum of systolic pressure and diastolic pres-
sure was reached. This was maintained during 30 min for four t imes. 
It is not known exactly how long distension must be exerted, nor 
how it really works. It is possible that it works: (a) by local ischemia of 
structures (the nerve cells being the most sensitive); (b) by breaking the 
nexuses between muscle fibres, or (c) by stretching the muscle fibres. 
After the distension, an indwelling catheter was left in situ for 
24-28 h. The patients were discharged 2 days after the distension. 
Table I I . Patients and methods 
Number 
Sex 
female 
male 
Age 
Urological and neurological 
investigation 
Duration of therapy prior 
to bladder distension 
Duration of distension 
Anesthesia 
general 
epidural 
Follow-up after distension 
22 
19 
3 
10—64 years (mean: 40 years) 
negative 
6 months to several years 
(propantheline bromide, emepronium 
bromide, flavoxate hydrochloride) 
4 x 30 min 
13 
9 
6—21 months 
COMPLICATIONS 
No patient complained of any pain after the distension. Hematuria, when 
present, was mi ld and disappeared in a few hours. In 2 cases, bladder 
rupture occurred during distension. Both patients were under epidural 
anesthesia and had complaints of abdominal discomfort. Coughing was 
the provoking factor. A suprapubic incision was made to close the rup-
ture, and simultaneously cystolysis was done. Both patients became 
completely free of symptoms. 
2 other patients had temporary atony of the bladder, proved by 
urodynamic investigation. Both returned to instabil i ty, 1 after 2 months, 
1 after 8 months. 
RESULTS 
Results were evaluated cl inically as well as urodynamical ly. 
As seen in table I I I , the clinical results were divided in responses 
to continence and to urgency. 
In the urodynamic investigation only presence or absence of insta-
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bility was taken into consideration. Decrease in the frequency and/or 
intensity of instability was often seen but these cases were considered as 
failures. Only when not even a minor contraction during bladder filling 
was seen, was the case then regarded as a success. 
As shown in table III and IV, only 6 patients became completely 
stable, all being perfectly continent. One of the continent patients had 
still some unstable contractions on the cystometrogram, although these 
were decreased. Inali failures, it seems that bladder distension had more 
influence on urgency than on continence. 
Table I I I . Clinical results (n = 22) 
Continence 
Perfectly continent 7 
Less incontinent 6 
Incontinence unchanged 9 
22 
Urgency 
Disappeared 2 
Decreased 10 
Unchanged 10 
22 
Only 2 patients were completely free of symptoms. 
In 9 cases the symptoms remained unchanged. 
11 patients noted moderate symptomatic improvement. 
Table IV. Urodynamic results (n = 22) 
Stable bladder 6 
Al l being continent 
Unstable bladder 16 
Perfectly continent 1 
Less incontinent 6 
Incontinence unchanged 9 
CONCLUSION 
Of the 22 patients, only 2 were completely free of symptoms. 7 patients 
were perfectly continent, but 5 patients still complained of urgency. 11 
patients noted moderate symptomatic improvement. In 9 cases, all the 
symptoms remained unchanged. It seems to us that bladder distension 
deserves a place inthetreatment of idiopathic bladder instability. It is an 
elegant and atraumatic method, with a success rate of about 30%. 
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Chapter V 
Prolonged bladder distension in the 
management of the unstable 
bladder (long-term results) 
K.P.J. Delaere, F.M.J. Debruyne, 
H.G.E. Michiels and W.A. Moonen 
From the Department of Urology, St Radboud University Hospital, Nijmegen, 
The Netherlands 
ABSTRACT 
We treated 63 patients with urinary symptoms associated with uninhibi­
ted detrusor contractions on cystometry by prolonged bladderdistension. 
All patients had received drug therapy previously without success. Four­
teen patients whose symptoms relapsed after a previous distension or 
who failed to obtain any improvement have had repeat distension. Post­
operative cystometry was done in 36 cases. Only in 7 patients (19 per 
cent) did the unstable pattern convert to stable bladder function. The 
results of symptomatic assessment were dependent upon the moment of 
followup, since many patients had relapses. After a 3-month followup 17 
per cent of the patients were cured and 29 per cent noticed some symp­
tomatic improvement. A subjective evaluation after 1 year revealed 11 
per cent cured and 21 per cent improved. The results after a second dis­
tension were even less than after prior distension. Complications inclu­
ded a ruptured bladder in 6 female subjects (8 per cent), 2 patients were 
temporarily unable to void spontaneously, while 1 patient still had atony 
of the bladder after б months of followup. 
Bladder distension appears to be of limited or doubtful value in 
the treatment of the patient with an unstable bladder. Moreover, when 
the high incidence of complications is considered we do not remommend 
this therapy to be pursued further. 
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In urological practice symptoms of urgency, frequency, nocturia, 
urge incontinence and nocturnal enuresis are common. These symptoms 
may cause embarrassing social and psychological disturbances. Cysto-
metric examination often reveals uninhibitable or unstable detrusor con-
tractions in such cases. In some patients the etiology of this dysfunction 
may be a urological disease, such as a urinary infection or an outflow 
tract obstruction in the male patient.1 In other cases of detrusor insta-
bility or unstable bladder a neurological disorder sometimes is found. 
However, urological and neurological examination cannot reveal any ab-
normality in most patients. In this event the instability is called primary 
or idiopathic. We are convinced that in the latter group of patients, 
mostly women, emotional and psychological factors have an important 
role,2 and the description 'psychosomatic unstable bladder' seems to be 
significant. 
The treatment of detrusor instability must be causative whenever 
possible in cases with a known origin. However, as mentioned previously, 
most cases of instability are idiopathic and, in these cases, the manage-
ment can only be symptomatic. Drugs remain the first choice of treat-
ment and the most common are propantheline bromide, emepronium 
bromide, Imipramine and flavoxate hydrochloride. Recently, some suc-
cess has been reported with bromocriptine3 but we have not been able 
to reproduce these promising results.4 
In general, the results of drug therapy often are disappointing. In 
cases in which medical treatment is ineffective and the symptoms are 
sufficiently severe one might try some more aggressive forms of treat-
ment, such as prolonged bladder distension,5-8 transection of the blad-
der,9*10 selective sacral neurectomy,11,12 multiple detrusor myotomy13 
and cystolysis. 
Hydrostatic pressure therapy was used first by Helmstein in the 
treatment of patients with bladder carcinoma.14,15 The purpose of this 
new procedure was to inducea reduction of the blood circulation of the 
bladder wall, thus causing anoxia and subsequent necrosis of tumor 
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tissue. Helmstem's distension therapy also has been advocated to treat 
patients with recurrent post-irradiation bleeding16 and interstitial cysti-
tis.17 
Recently, we reported our initial results with bladder distension 
for detrusor instability.18 Our over-all success rate was 30 per cent. The 
aim of this study is to assess the current results, with particular reference 
to the long-term results and the efficacy of repeat distensions. 
MATERIALS AND METHODS 
From January 1975 to May 1978 we performed 77 prolonged bladder 
distensions on 56 female and 7 male patients, ranging m age from 7 to 64 
years (mean 36 years). All 63 patients presented with a history of urgen-
cy, urge incontinence, frequency, nocturia and nocturnal enuresis. A full 
urological examination was done, including urinalysis, blood chemistry, 
excretory urography, cystography and cystoscopy. 
All of the patients demonstrated unmhibitable detrusor contrac-
tions on a cystometrogram Urinary infection and outflow obstruction 
as causes of the unstable bladder could be excluded. Of the 63 patients 
8 had a neurological disorder: 1 patient had spastic tetraplegia, 1 had a 
traumatic upper motor neuron lesion and 6 had been operated upon for 
a meningomyelocele. In all patients drug therapy (propantheline bro-
mide, emepromum bromide, Imipramine and flavoxate hydrochloride), 
administered for several months to several years, had failed to produce 
a satisfactory improvement. Followup ranged from 3 to 40 months. 
Sixty-seven bladder distensions were done under general anesthesia, 
while high epidural anesthesia was used m the remaining cases. 
A modified technique of bladder distension was used, according 
to the original work of Helmstem.14 After the bladder was emptied a 
Couvelaire catheter, onto which a condom was tied securely, was intro-
duced into the bladder. The catheter was connected to a plastic bag of 
sterile saline solution, on which pressure could be exerted using the pres-
sure cuff of a sphygmomanometer. A Lewis cystometer was used to 
measure the pressure within the closed system. The bladder was disten-
ded to a pressure approximating the systolic blood pressure of the pa-
tient for 4 consecutive periods of 30 minutes, with intervals of 10 minu-
tes. 
Blood pressure was lowered deliberately as much as possible, with 
the purpose of lowering the intravesical pressure correspondingly for fear 
of bladder rupture. The mean systolic blood pressure was 112 mm. Hg 
(standard deviation 13.6) and the mean diastolic pressure was 73 mm. 
Hg (standard deviation 10.6) Because we initially did not dare to distend 
the bladder to the level of systolic pressure the mean intravesical disten-
sion pressure was slightly less than the systolic blood pressure, namely 
104 mm. Hg (standard deviation 11.9). 
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At the end of the distension the catheter with the condom was re-
moved and an indwelling Foley catheter was left in situ overnight. Usu-
ally, the patient was discharged from the hospital the next day if normal 
micturition without retention was possible. 
RESULTS 
Results were evaluated symptomatically as well as urodynamically.Symp-
tomatic assessment was done at intervals and was attested as cured, im-
proved, unchanged and worse (fig. 1 and table 1). Patients were consi-
dered to be cured subjectively if they no longer complained of urgency, 
frequency, nocturia and incontinence. When these complaints were re-
duced by about 50 per cent the result was attested symptomatically as 
improved. There is a tendency to relapse, especially during the first 6 
months after distension (fig. 2). 
Postoperative cystometric assessment was done in 36 patients. In 
this group the mean bladder capacity before bladder distension was 305 
ml. (standard deviation 175). There was a mean increase in capacity of 
69 ml. (23 per cent). In 7 cases (19 per cent) the postoperative cysto-
metrogram could not show any unstable bladder contractions. One fe-
male subject, who at recent assessment (6 months after the bladder dis-
tension) was still unable to empty the bladder, showed a large non-con-
tractile bladder on cystometry. In the remaining 28 patients (78 per cent) 
the cystometrogram did not change to a stable pattern. Table 2 shows 
the relationship between postoperative cystometric and symptomatic 
findings. 
Complications included 6 bladder ruptures (8 per cent). In 2 cases 
bladder rupture occurred under epidural anesthesia and coughing was the 
provoking factor. In the remaining 4 cases the distension had been done 
under general anesthesia. The intravesical pressure at which the rupture 
occurred was similar to the mean intravesical pressure of the uncompli-
cated distensions. The 2 intraperitoneal and 4 extraperitoneal ruptures 
were closed at laparotomy and cystolysis was done simultaneously. Four 
patients seemed to have benefited temporarily from the procedure. Two 
other female subjects were temporarily unable to empty the bladders and 
Table 1. Symptomatic assessment at various intervals after distension 
No. distensions 
Cured 
Improved 
Unchanged 
Worse 
1 Mo. 3 Mos. 
No. (%) No. (%) 
77 77 
19(25) 13(17) 
25 (32) 22 (29) 
27 (35) 37 (48) 
6 (8) 5 (6) 
6 Mos. 12 Mos. 
No. (%) No. (%) 
59 38 
6(10) 4(11) 
16(27) 10(21) 
33 (56) 22 (63) 
4 (7) 2 (5) 
24 Mos. 36 Mos 
No. (%) No. (%) 
17 8 
3 (18) 2 (25) 
12(70) 6(75) 
2(12) 
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Figure 1. Symptomatic evaluation after 77 bladder distensions in 63 patients. 
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Figure 2. Followup of positive clinical results after bladder distension. 
?100 
ln=77) (n=59) 
12 months 18 24 
(n=38) (п=2б) (n=17) 
Table 2. Postoperative cystometric findings in 36 of 63 patients 3 months after 
distension and the corresponding symptomatic results 
Bladder: 
Stable 
Unstable 
Atonic 
Totals 
Preop. 
No. Pts. (%) 
63 
Cystometry 
Postop. 
No. Pts. (%) 
7 (19) 
28 (78) 
1 (3) 
36 (100) 
Symptomatic 
Assessment 
No. Pts. 
Cured, 5 
Improved, 2 
Cured, 2 
Improved, 8 
Same, 16 
Worse, 2 
Worse 
36 
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they required catheterization. These 2 patients had no sense of a ful l 
bladder postoperatively and spontaneous mic tur i t ion could not be indu-
ced. Voiding again became possible rather abrupt ly , after 2 and 4 weeks, 
respectively. Unfortunately, complaints of urgency, frequency and incon-
tinence recurred immediately. It seemed as if a postdistension non-con-
tracti le bladder had suddenly turned into an unstable bladder. A young 
female subject, already 6 months after distension, still performs self-ca-
theterization because of a flaccid decompensated bladder. It seems that 
the bladder wi l l remain atonic irreversibly. Cystalgia developed in 1 pa-
tient in the immediate postoperative period. The results after 14 repeat 
distensions are shown in table 3. The responses were even worse than 
after the initial distension. Distension therapy appears to be of no value 
at all in patients w i th a neurogenic unstable bladder (table 4). 
Table 3. Comparison of results after first and repeat distension in 14 patients 3 
months after each distension 
First Distension 
No. (%) 
Second Distension 
No. (%) 
Cured 
Improved 
Same 
Worse 
• 3 ] 4 <2 9) 
Table 4. Results after distension for neurogenic bladder in 8 patients 3 months after 
distension 
Neurological Disorder No. Pts. Effect of Distension 
Spina bifida 
Spastic tetraplegia 
Spinal cord injury (upper 
motor neuron lesion) 
Improved, 2 pts. 
Unchanged, 4 pts. 
Unchanged 
Unchanged 
DISCUSSION 
There is much controversy as to the effectiveness of distension therapy 
in the management of patients wi th an unstable bladder. The early results 
obtained in 1974 by Dunn and associates5 and the later results f rom the 
same center7 were encouraging. However, the enthusiasm of Whitf ield 
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and Mayo was more moderate.6 A recent publication of Pengelly and 
associates even reported disappointing results.8 Our initial experiences 
with the distension technique18 were such as to continue with this pro-
cedure, the more so because we thought we had not much more to offer 
in severe cases of bladder instability not responding to medical treat-
ment. 
Not much is known about the mechanism by which prolonged 
bladder distension would exert its possible beneficial effects. It is possi-
ble, theoretically, that overdistension of the bladder will be followed by 
ischemic and mechanical damage to the nerve terminals as well as the 
smooth muscle cells within the bladder wall. However, Gosling and asso-
ciates used light and electron microscopy to study the structure of the 
rabbit bladder after distension and have shown that muscle cells and 
muscle nexuses remain unaffected." Nevertheless, changes in the nerve 
terminals, suchasaxonal degeneration, could be demonstrated in animal 
experiments20 and may be responsible for the possible action of bladder 
distension. 
The duration (4 times 30 minutes) and pressure of distension (pa-
tient's systolic blood pressure) partly have been determined empirically 
by Dunn and associates,5 and in most clinical studies this regimen is used. 
We wonder whether it is important to distend the bladder above the pa-
tient's systolic blood pressure with the intent to overcome the elasticity 
of the condom. In our series the over-all results in 16 patients whose 
bladders were distended to an intravesical pressure of about 15 mm. Hg 
above the systolic blood pressure did not differ from the results follo-
wing distension to a pressure equal to or just below the systolic pressure. 
It also may be questioned why distension for 1 hour is not satis-
factory or why distension for 2 hours is perhaps even insufficient. Fur-
thermore, one may ask whether the continuous distension is preferable 
to the intermittent procedure. According to Pengelly and associates 
there is no significant difference whether one uses a continuous 2-hour 
distension or an interrupted distension for 4 consecutive periods of 30 
minutes.8 
The followup after distension has, unfortunately, proved that the 
incidence of relapse is high, especially during the first postoperative 
months. A repeat distension was thought to be indicated if a prior dis-
tension was curable at the outset. However, generally the results after a 
second distension are less favorable than after a first distension. Our li-
mited experience of the distension technique in the neurogenic unstable 
bladder suggests that this procedure is of no avail in these severe cases. 
It is not easy to evaluate the results of this treatment because, in 
the first place, we have only the patients' indications. The fact that, 
emotional and psychological factors possibly have an important role in 
the genesis of the voiding disorders in many patients makes it harder still 
to assess correctly the postoperative subjective data. Moreover, we have 
no clear idea yet of the natural history of unstable bladders. It is known 
53 
that some patients may get better on their o w n , while others may prof i t 
f r o m centain forms of autosuggestion and biofeedback. 2 1 A l though con­
trols have not been provided we believe that the data obtained suggest 
that prolonged bladder distension does not solve the problem of the un­
stable bladder. The high incidence of complications is yet another reason 
not t o recommend the future use of this therapy. 
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Part II 
Emptying disorders of the bladder 
Chapter VI 
The Value of Intravesical 
Prostaglandin E2 and F2a in 
Women with Abnormalities of 
Bladder Emptying 
K.P.J. Delaere, C.M.G. Thomas, W.A. Moonen 
and F.M.J. Debruyne 
Departments of Urology and Obstetrics and Gynaecology, St Radboud 
Hospital, Nijmegen, The Netherlands 
SUMMARY 
A clinical study of intravesical prostaglandin E2 (PGE2) and F2a (PGF2a) in the treatment of 13 female patients with difficulties in emp­
tying their bladder is reported. Urodynamic investigations were perfor­
med before and after instillation of the drug. Although 3 patients had 
some reduction in residual urine volume, the remainder showed no obvi­
ous change and no patient experienced subjective improvement. In б pa­
tients, biopsies of the vesical mucosa were taken before and after instil­
lation in order to measure the uptake of prostaglandin by the mucosa, 
but no conclusions could be drawn from these measurements. 
Although prostaglandins are known to have contractile effects on 
the detrusor muscle, the results of this study suggest that intravesical 
PGE2 and PGFitt have no therapeutic value in the treatment of voiding 
dysfunction and residual urine. 
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Medical treatment of impaired voiding w i t h chronic retention of 
urine often proves ineffective. When there is no mechanical bladder out­
let obstruction and the detrusor muscle fails t o contract, the administra­
t ion of cholinergic agents such as carbachol is the usual treatment. Never­
theless, one is often confronted w i t h the clinical ineffectiveness and the 
unacceptable systemic side effects of these drugs. In some cases, mode­
rate success may be expected f r o m the administration of alpha-blocking 
agents such as phenoxybenzamine, with the aim of decreasing urethral 
resistance. Therefore there is a clear need for drugs that wi l l induce or 
augment detrusor contract i l i ty as well as decrease o u t f l o w resistance 
(Bissada, 1979). It seems that PGE2 is able to stimulate the bladder 
while reducing the urethral tone. 
Recently, Bult i tude et al. (1976) and Andersson et al. (1978) re­
ported success w i t h the intravesical insti l lation of PGE2 in female pa­
tients w i t h d i f f i c u l t y in mictur i t ion and chronic or acute retent ion. Ani­
mal experiments have shown that PGE2 and PGF 2 a have contracti le ef­
fects on isolated strips of detrusor muscle (Ambache and Zar, 1970; 
Bult itude et al., 1976; Hills, 1976; Khanna et al., 1978). 
Human studies have demonstrated that РСРг» has the most po­
tent contracti le effect upon bladder muscle, approaching that of acetyl­
choline (Abrams and Fenely, 1976). On the other hand, Khanna et al. 
(1978) stated that the stimulating effect of PGE2 on bladder muscle of 
the rabbit was twice that of РСРга. 
The action of PGE2 and PGF 2 a on urethral smooth muscle is con­
troversial; it seems that PGE2 reduces urethral resistance (Persson, 1976; 
Andersson et al., 1977, 1978), but this relaxing effect on the urethra 
was not noted by Khanna et al. (1978). 
Prostaglandin F 2 a has been shown t o have contracti le effects on 
the urethra (Andersson et al., 1977; Khanna et al., 1978). 
In the present study, the action of intravesical PGE2 and Р&?
г
а. 
has been assessed in female patients wi th diff icult ies in emptying their 
bladder. The effects were assessed by urodynamic studies carried out be-
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fore and after inst i l lat ion. In some cases the absorption of prostaglandin 
through the vesical mucosa was studied by radioimmunoassay (RIA) of 
prostaglandins m biopsies taken before and after insti l lat ion. 
PATIENTS A N D METHODS 
Thirteen female patients wi th diff icult ies m emptying their bladder were 
investigated and treated w i th either PGE2 or PGF 2 a. Their ages ranged 
f rom 18 to 75 years (mean 47 years). Eighteen bladder instillations were 
performed, 13 wi th PGE2 and 5 wi th PGF 2 a. 
Nearly all patients had received previous treatment with carbachol 
w i thout success. About half of the patients had received phenoxybenza-
mme, which had also failed to relieve their symptoms. The causes of their 
problems are listed m Table 1. 
Table 1 
Number Case Aetiology of voiding 
of number dysfunction 
patients 
5 (1,2,7,8,13) Unknown 
4 (3,9,11,12) One of more previous 
anterior vaginal repairs 
1 (4) Prolonged bladder distension 
for nocturnal enuresis 
1 (6) Multiple Sclerosis 
1 (10) Occult neuropathic bladder 
1 (5) Post-operative overdistended 
bladder 
Each woman underwent a ful l urodynamic examination, including 
a f i l l ing and micturat ing cystometrogram and a urethral pressure profi le, 
just before the application of the drug. The bladder was f i l led at a con-
stant rate of 50 ml/s. Special attention was paid to functional bladder 
capacity, detrusor pressure at maximum f low, abdominal straining during 
mic tur i t ion , maximum f l ow rate and residual urine volume. Addi t ional 
abdominal straining to urinate was found in all patients; 7 patients had a 
completely atonic bladder and 4 of these failed to micturate. A l l patients 
had residual urine volumes ranging f rom 50 to 1100 ml , wi th an average 
of 470 m l . The urodynamic measurements are presented m Table 2. 
The urethral pressure profi le was performed according to the me-
thod of Brown and Wickham (1969). It is important to mention that any 
evidence of mechanical bladder outlet obstruct ion could be excluded by 
means of urethral cal ibration, endoscopy, pressure/flow analysis and 
micturat ing cystourethrography. 
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In 6 patients biopsies of the vesical mucosa were taken during cys-
toscopic examination, in order to determine the concentration of PGE2 
and PGF2a before application of the drug. The tissue samples were im­
mediately frozen in liquid nitrogen and stored at — 70°С until assay. 
Then the frozen tissue was weighed, washed once in isotonic saline and 
homogenised in a small Potter-Elvehjem glass homogeniser. Prostaglan­
dins were determined according to the method previously described by 
Thomas et al. (1978a, b). 
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After urodynamic investigation the bladder was emptied through 
a urethral catheter and a known amount of PGE2 or РСРга was dissol­
ved in 50 ml sterile disti l led water and instilled into the bladder (Table 
2). The drug was kept in the bladder for 30 min in 9 patients, 60 min in 
7 patients, and 90 and 120 min in 2 patients. The cystometrogram and 
the urethral pressure profi le were repeated at the end of this procedure. 
In the patients who underwent a bladder biopsy before treatment, a new 
biopsy was taken after insti l lation and this was also immediately frozen 
in the same way. 
Table 3 
Pattern. Age PG;dose Duration of Tissue concentrations of prostaglandins* In 
no. (years) instillation biopsies taken before and after Instillation 
1 
2 
3 
4 
5 
10 
54 
25 
70 
18 
38 
23 
E, ;0.5 mg 
E 2 ; 0.5 mg 
E 2 ; 0.5 mg 
E, ; 0.5 mg 
E, ; 1 mg 
F,α; 1 mg 
30 
30 
30 
30 
60 
30 
PCF,» 
Before 
938 
633 
164 
850 
958 
99 
After 
537 
249 
153 
921 
1161 
51 
PGEj 
Before 
68 
378 
91 
190 
366 
256 
After 
99 
37 
88 
381 
190 
381 
•Means of duplicate measurements; values are expressed In pmol PG/g frozen tissue. 
RESULTS 
In general, the urodynamic parameters did not change significantly after 
insti l lation (Table 2). A l though the data obtained f r o m the urodynamic 
study after insti l lation showed some improvement in the mictur i t ion 
pattern (nos. 1, 2 and 9), none of the patients benefited subjectively f r o m 
the treatment. Three patients (nos. 2, 3 and 10) felt some urgency and 
suprapubic discomfort at the end of the inst i l lat ion, but these complaints 
disappeared wi th in 24 h. We observed no differences between the ure­
thral pressure profiles recorded before and after treatment. The results 
of the biopsies are shown in Table 3. 
Higher doses of the drug ( > 0.5 mg) and/or a longer insti l lation 
t ime did not affect the results. 
DISCUSSION 
Bult i tude et al. (1976) were the first t o use PGE2 intravesically and they 
noted a response in 14 of 21 females w i t h voiding ineff iciency. They in­
stilled the bladder w i t h only 0.5 mg PGE2 during 30 m i n . 
A l though prostaglandins have a relatively short half-life (P ipere i 
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al , 1970), the effects after a single application of PGE2 lasted in many 
patients for several months, and even up to 2 years. Andersson et al. 
(1978) were not able to reproduce these favourable effects with a dose 
of 0 5 mg PGE2 They used doses ranging from 4 to 10 mg (mostly 5 mg) 
and m this way a small increase in bladder pressure was shown imme-
diately after treatment m the 9 females studied. However, none of these 
effects persisted at re-exammation after 7 to 10 days. 
To our knowledge, there have been no previous studies using intra-
vesical PGF2OÍ m patients with dysuria and residual urine. The fact that, 
m our study, no beneficial effects were noted following administration 
of PGE2 , even with doses of 10 mg, prompted us to try PGF2a Moreover, 
Abrams and Fenely (1976) demonstrated that the contractile effect of 
PGF2CÏ was greater than that of PGE2 on human bladder muscle. Again, 
PGF2a was ineffective in restoring bladder function in our patients 
Measurements of the biopsies of vesical mucosa taken before and 
after instillation did not allow conclusions to be drawn regarding the up-
take following instillation about half of the pairs tested showed either 
an increase or a decrease m prostaglandin levels m the tissue. 
In additional control experiments (4 normal functioning bladders) 
the prostaglandin concentrations were determined in 2 simultaneous 
biopsies (left and right sides) from the same bladder, and the levels 
measured showed a 2-fold variation This can be explained by the pre-
sence of aggregating blood platelets that are known to synthesise and re-
lease prostaglandins (Smith and Willis, 1970). Furthermore, surgical 
trauma is also associated with a marked increase m prostaglandin con-
tent (Angglrd and Jonsson, 1972), thus probably leading to unreliable 
determinations of prostaglandin tissue levels m biopsies 
It is concluded that despite the known effects of PGE2 and P G F 2 Q 
on bladder muscle tone and contractility, these drugs appear to be inef-
fective in the treatment of patients with difficulty in micturition. 
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Chapter VII 
Some aspects of large cystocele 
and its treatment by colpo- or 
hysteropexy to the sacral 
promontory 
K.P.J. Delaere, W.A. Moonen and 
F.M.J. Debruyne 
Department of Urology, St Radboud University Hospital Nijmegen, 
The Netherlands 
SUMMARY 
Clinical findings caused by large cystocele in 22 female patients are re-
ported. Special attention is paid to the voiding difficulties, including the 
typical micturition in a bent position. Obstructive urinary symptoms in 
association with extreme descent of the bladder may be due to obstruc-
tive urethral distortion and/or the fact that a large cystocele acts as an 
energy destroyer. Due to a misunderstanding of the pathogenesis, some 
of the patients had received prior medical and/or endoscopic treatment 
for the relief of their presumed outflow obstruction without benefit. A 
simple operative procedure by theabdominal route for cure of the cysto-
cele is described. The operation consists of a fixation of the vaginal vault 
or uterus to the sacral promontory. As a precaution against postopera-
tive stress incontinence, a complementary suspension of the anterior 
vaginal wall to Cooper's ligaments seems desirable. The overall cure rate 
was about 70%. 
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Urinary symptoms in female patients are often related to some prolapse 
of the anterior vaginal wall. Generally a slight descent of the bladder base 
may be associated with urinary incontinence, while a gross anterior vagi-
nal prolapse or a large cystocele can lead to obstructive urinary symp-
toms. A simultaneous occurrence of incontinence and bladder outflow 
obstruction may appear in association with urethro-vaginal prolapse. 
It is well-known that in case of pure stress incontinence a re-posi-
tioning operation will restore urinary control. Much less is known about 
the favourable effect of repositional surgery on inefficient voiding asso-
ciated with bladder descent.1 The aim of this report is to assess the im-
portance of massive cystocele as a cause of difficult voiding. A surgical 
technique, consisting of a fixation of the vaginal vault or the uterus to 
the sacral promontory, creates a reduction or a correction of the bladder 
prolapse, leading to an improvement in micturition. 
PATIENTS 
Twenty-two females were operated upon because of marked cystocele 
which was considered responsible for impaired voiding efficiency. Their 
ages ranged from 38 to 65 (average 53 years). The postoperative followup 
period varied from 6 to 36 months. All patients presented with a histo-
ry of dysuria, poor and intermittent stream, hesitancy, abdominal strai-
ning and sense of incomplete evacuation. Twenty females reported being 
unable to urinate in the conventional sitting position. They had to empty 
their bladders in a bent position. Several women micturated in a squee-
zing manner inclining forward with their heads near the ground. Addi-
tional urinary symptoms were: slight stress incontinence in 9 females, re-
current cystitis in 4 patients and urinary retention in another 6 patients. 
Four females also complained of a feeling of prolapse. 
Physical examination showed an extensive prolapse of the anterior 
vaginal wall or a descent of the bladder outside the vulva on straining. 
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Intravenous pyelography showed no obvious abnormalities. In all pa-
tients a lateral cystogram illustrated a marked prolapse, principally of 
the dorsal part of the bladder base. Urodynamic investigation showed 
usually a large capacity bladder. A pressure/flow analysis revealed a nor-
mal or a rather low voiding pressure wi th a decreased f low rate. Bladder 
neck obstruct ion and obstruction at the site of the distal urethra were 
considered to be excluded as a cause of dysuria on the basis of urethral 
cal ibration, urethro-cystoscopy, micturating photographs and the data 
obtained by the pressure/flow analysis. Of the 22 patients, 16 had al-
ready been operated upon for mictur i t ion disturbances and/or problems 
associated wi th genital prolapse. The surgical interventions that had been 
performed — mostly elsewhere — were the fo l lowing: hysterectomy, 
both vaginal and abdominal (13 times), anterior vaginal repair (12 times), 
suprapubic colpo-urethropexy according to Marshall-Marchetti-Krantz2 
or Burch3 (7 t imes), bladder neck resection or incision (6 times) and in-
ternal urethrotomy (5 times). It wi l l be clear that some women had un-
dergone more than one previous operation and it was probable that the 
disobstructive interventions had been unnecessary; we th ink that ini t ial ly 
it had not been recognized that the obstructive urinary symptoms had 
been the results of a pronounced cystocele. Many patients had also been 
submitted to medical treatment,consisting of cholinergic drugs and alpha-
adrenergic blocking agents wi th the intent ion of increasing the detrusor 
tone and decreasing the outlet resistance respectively. In most cases this 
pharmacologic treatment did not correct the dysfunct ion. 
OPERATIVE TECHNIQUE 
The abdomen is opened through a median subumbilical incision. After 
the intestines have been retracted upwards, the sacral promontory can 
easily be brought into sight. The overlying posterior parietal peritoneum 
is divided longitudinal ly over 3 to 5 cm. Care is taken not t o injure the 
left common iliac vein which passes near the midl ine at the level of the 
5th lumbar vertebra. Also attention must be paid to the course of the 
ureters. Therefore the dissection of the promontory is confined to the 
midl ine area. With the help of a prosthesis pre-operatively placed in the 
vagina, the vaginal vault is pushed upwards and two or three silk sutures 
are inserted through it. These stitches are then attached to the superficial 
ligaments of the promontory or the intervertebral disc. In this way the 
vagina is approximated to the promontory and the cystocele is stretched 
and disappears. It is not always possible to bring the vaginal vault into 
direct contact w i th the promontory . In these cases free suture material 
is buried under the posterior peri toneum, or a strip of fascia can be used 
to bridge the distance. If the uterus is still present, the sutures approxi-
mate the posterior part of the cervix or the uterine body to the lumbo-
sacral junc t ion . 
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Since it is well-known that successful repair of a very large cysto-
cele might result in postoperative stress incontinence, we have been in­
clined to complete the procedure with some sutures fixed laterally in the 
anterior vaginal wall and attached to Cooper's ligament. In cases of co­
existing stress incontinence, this additional anti-incontinence procedure 
is always performed. Moreover in our opinion this associated colposus-
pension according to Burch3 diminishes the traction of the vaginal vault 
to the promontory. Postoperatively an indwelling catheter is left and the 
patient is confined to bed for a few days. 
RESULTS 
The most striking finding postoperatively was that most women enthu­
siastically reported to be able to micturate again easily, in a sittingstraight 
position without straining. Of the 22 patients, 16 regained a normal voi­
ding pattern, whereas 3 obtained only a moderate improvement. In the 
remaining 3 the colposuspension failed. It might be that co-existing ure­
thral fibrosis, as a result of a previous anterior colporrhaphy, was mainly 
responsible for the inability to relieve the obstructive urinary symptoms 
in some patients. 
In б of the 9 cases of cystocele associated with stress incontinence, 
the combined colpof ixation to the promontory and to Cooper's ligament, 
led to continence and efficient micturition. 
In the group of 13 patients with cystocele without incontinence 
this combined procedure was performed in 4 cases. All remained conti­
nent. In the remaining 9 patients, only a colpo- or hysteropexy to the 
promontory was carried out. Postoperatively 1 woman developed a 
slight stress incontinence. Subsequently a complementary Burch-suspen-
sion was necessary to restore continence. 
All the 6 females with residual urine were postoperatively able to 
empty their bladders completely. Lower urinary tract infections persis­
ted in 2 of the 4 cases. 
COMPLICATIONS 
In 1 case the left common iliac vein was injured, with profuse hemor­
rhage. In 2 cases in which we used catgut stitches to achieve an approxi­
mation of the vaginal dome or the uterus to the promontory, the fixation 
disrupted after 2 and 4 months respectively. These patients required a 
repeat suspension which was carried out with unabsorbable sutures and 
yielded good results. 
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DISCUSSION 
An impaired balance between detrusor activity and urethral resistance 
may result in obstructive symptoms such as dysuria, abdominal strai-
ning, hesitancy, poor stream, insufficient emptying of the bladder and 
residual urine. In women complaining of difficulties with voiding, de-
monstrable bladder outflow obstruction would appear to be relatively 
uncommon4,5. The commoner cause of female voiding inefficiency is 
bladder dysfunction, either of a functional or a morphological nature. 
Diminished or absent voiding forces and an unsustained contraction may 
be evidence of neuropathic bladder dysfunction, postoperative overstret-
ching of the bladder or pharmacologic inhibition of bladder contractility. 
Little has been reported about the possible role of changes in the shape 
of the bladder in the pathogenesis of impeded and incomplete micturi-
tion. A large cystocele or a gigantic vesical diverticulum can lead to a 
loss of energy in transporting urine, resulting in a poor flow rate. These 
morphological alterations of the bladder are suspected to act as < energy 
destroyers >6. Another explanation of inefficient voiding is obstruction 
due to the distortion created by urethro-vesical prolapse or a large cysto-
cele.7 
The diagnosis of a massive cystocele is always clinical. In the up-
right position and/or on straining, a marked bulging of the anterior vagi-
nal wall appears outside the vulva. If the uterus is still present, a uterine 
descent may accompany or lead to the prolapse of the bladder. Clinical 
features due to a large cystocele may be complaints of feeling of weight 
and bearing down in the pelvis. In addition, residual urine and urinary 
infections are frequent. It is our experience as well as that of some other 
authors6,7,8 that women with pronounced cystoceles have problems in 
emptying their bladder; they have to urinate with additional effort in a 
< bent position >9. To our knowledge this typical posture of micturi-
tion has not been stressed elsewhere. Unsatisfactory micturition caused 
by a large cystocele appears to be often misjudged. Due to this misunder-
standing, bladder neck resections or incisions and internal urethrotomies 
are often performed with the intention of relieving the obstructive symp-
toms, in most cases however without the anticipated success. On the 
other hand urinary incontinence tends to be ascribed too often to exten-
sive descent of the anterior vaginal wall. However it has been demonstra-
ted that with increasing descent, incontinence appears less frequently.8,10 
This good urinary control in women with extreme prolapse of the bladder 
can be explained among other things by the base plate concept of Hutch.8 
Whereas the base plate on a lateral cystogram in case of stress inconti-
nence is funnelled, in the case of a large cystocele the base plate may re-
main flat and the patient will be free of urinary incontinence.8 Conver-
sely there is the well-known phenomenon that excellent surgical cure of 
cystocele may result in the development of stress incontinence because 
the bladder base has obtained a more or less coneshaped position. 
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With regard to the surgical treatment of marked cystocele, there 
have been many techniques proposed using the vaginal and abdominal 
approaches. Since urologists usually have less experience in operating 
vaginally and inasmuch as we are often confronted with voiding disorders 
after anterior vaginal repair,9 we have chosen correction via the supra­
pubic transperitoneal route. The vaginal vault, or the uterus if still pre­
sent, is suspended to the lumbo-sacral promontory. Such an operation 
has been described elsewhere as sacral hysteropexy for the cure of uterine 
prolapse and prolapse of the vaginal vault11 or posterior suspension to 
the lumbo-sacral disc.12 
It is concluded that alterations in the shape of the bladder, such as 
large cystocele, may lead to obstructive voiding disorders. Suprapubic 
repositional surgery has proven to be effective in about 70% of the pa­
tients. 
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Chapter Vili 
Extended Bladder Neck Incision for 
Outflow Obstruction in Male 
Patients 
K.P.J. Delaere, F.M.J. Debruyne and 
W.A. Moonen 
Department of Urology, St Radboud Hospital, Catholic University of Nijmegen, 
Nijmegen, The Netherlands 
SUMMARY 
Thirty-two male patients with mechanical or functional bladder outlet 
obstruction were treated by bilateral endoscopic bladder neck incision. 
In three cases a repeat incision was necessary. Subjective cure or improve-
ment was obtained in 81%. Objective evaluation, including uroflowmetry 
and residual urine measurements, showed a similar improvement. Bladder 
neck incision takes only a few minutes, is simple and less traumatic than 
transurethral resection. The aetiology of impaired micturition and the 
value of urodynamic assessment are discussed and some attention devoted 
to the problem of post-operative retrograde ejaculation. 
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Bladder outflow obstruction is a common urodynamic problem in 
male patients. In the elderly patient, an enlarged prostate is usually res-
ponsible, and open prostatectomy or transurethral resection are the pre-
ferred methods of treatment in such cases. However, in the case of early 
limited prostatic enlargement, sometimes occurring in younger men, 
conventional procedures may be undesirable. 
This report deals with obstruction located at the level of the 
bladder neck. As its aetiology can be very varied, it is particularly impor-
tant to perform urodynamic studies with micturating cystography to 
define the true nature of the outflow impairment, since obstruction can 
be caused by an anatomical as well as a functional disorder at the bladder 
neck. Detrusor failure has also to be taken into account. 
Since the report by Turner-Warwick et al. (1973) on bladder neck 
dysfunction and its treatment by endoscopic diathermy incision, we 
have used this simple method instead of conventional transurethral 
bladder neck resection. 
Hypertrophy or sclerosis of the bladder neck are indications for 
incisions, as is functional bladder neck obstruction. Physiological or 
functional bladder neck obstruction, caused by inefficient bladder neck 
opening or tightening of the bladder neck during micturition, is probably 
the result of deviation of the muscle fibres at the bladder neck (Turner-
Warwick et al., 1973; Bates et al., 1975). This is described by Turner-
Warwick et al. (1973) as 'dyssynergic bladder neck occlusion'. Some 
neurogenic and atonic bladder disorders which appear to have normal 
bladder necks may also be treated in the same way. Another indication 
for an 'extended' bladder neck incision is minimal hypertrophy of the 
prostate (Keitzer et al., 1969; Grandi, 1973; Jenkins and Allen, 1978; 
Moisey et al., 1982) or the trapped prostate (Turner-Warwick et al., 
1973). However, if no anatomical abnormalities of the bladder neck are 
present, one may often expect a favourable response to alpha-sympatho-
lytic agents such as phenoxybenzamine. 
Various descriptions have been used to define bladder neck ob-
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struction (Table 1). Some of these terms are confusing in the sense that 
they do not always differentiate exactly between funct ional and anato-
mical ou t f low obstruct ion. Nevertheless, it must be emphasised that it 
is not always easy or even possible to define the clear nature of the ob-
structed mic tur i t ion . 
This study describes 35 extended bladder neck incisions in 32 
male patients who suffered f rom inefficient voiding of various aetiologies. 
Our experience wi th bladder neck incision in female patients, presented 
elsewhere, has shown that both the indications and the results are diffe-
rent in the two sexes (Delaereef a/., 1983). 
Table 1. Some Terms Used to Determine Bladder Neck Obstruction 
'Prostatisme sans prostate' 
'Sclérose du col' (Marion's disease) 
Median bar 
Congenital fibro-elastosis of the bladder neck 
Bladder neck contracture 
Achalasia of the bladder neck 
Dyskinesia 
Dysectasia 
Sphincter sclerosis 
Bladder neck sclerosis 
Bladder neck hypertrophy 
Trapped prostate 
Dyssynergic bladder neck occlusion 
PATIENTS A N D METHODS 
Thi r ty - two consecutive male patients, aged f rom 32 to 84 years (mean 
60 years), were studied. Nearly all presented w i th voiding diff icult ies, 
e.g. hesitancy, nocturia, frequency, urge and poor intermit tent stream. 
Post-voiding residual urine was present in 14 patients (44%). Urof low-
metry showed a mean maximum f low rate of 7.1 ml/s (SD 4.79). Each 
patient underwent a cystourethroscopic examination to evaluate the 
appearance of the bladder neck, the degree of prostatic enlargement and 
bladder trabeculat ion. If there was no mechanical outlet obstruct ion, a 
ful l urodynamic investigation (f i l l ing cystometrogram, pressure/flow 
analysis and urethral pressure profi le) was carried out to see if dysfunc-
t ion of the bladder neck opening mechanism or an acontractile bladder 
were present. In these dubious cases, a videocystogram was performed. 
Intravenous urography was done in all cases. 
The indications for endoscopic bladder neck incision are given in 
Table 2. In most patients wi th funct ional ou t f low impairment, medical 
treatment wi th phenoxybenzamine had been given, but wi th undesirable 
side effects and/or w i thout satisfactory relief of the obstructive symp-
toms. 
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Table 2. Indications for Bladder Neck Incision in Male Patients (n = 32) 
No. of % 
patients 
Functional outf low obstruction 4 12.5 
Mechanical outf low obstruction 81.5 
small obstructive prostate 7 
secondary bladder neck sclerosis 
after prostatectomy 11 
after TUR prostate 8 
Detrusor failure 2 6 
Extended bladder neck incision 
The technique has been described in detail by Turner-Warwick et al. 
(1973). With a vertical knife electrode (Collings' knife), two deep dia-
thermy incisions are made on the bladder neck at 4 and 8 o'clock. It is 
important that the incisions are deep enough, so that the perivesical fat 
appears and the bladder neck springs open. The incisions should be ex-
tended interiorly to the verumontanum. An indwelling Foley catheter is 
left in situ for one or two days. 
RESULTS 
Patients have been followed up for 6 to 44 months (mean 18 months). 
Symptoms and objective parameters were reassessed 3 months after sur-
gery. Symptomatic improvement and total cure were achieved in 81% of 
the patients (Table 3). Three patients required re-incision because the 
primary incision did not seem to be deep enough. Subjective recovery 
occurred later on, and only these subsequent results are included in 
Table 3. 
Table 3. Subjective Results after Bladder Neck Incision 
No. of % 
patients 
Cured 21 65.5 
Improved 5 15.5 
Unchanged 6 19 
Worse 0 0 
32 100 
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Max flow rate -
(ml/sec) 
40 -, 
3 0 -
2 0 -
1 0 
O - 1 
Figure 1. Flow rate data before and 
after incision. 
Pre-operative Post-operative 
Residual urine volume 
(ml) 
1?00 
1000 
Θ 0 0 
6 0 0 
4 0 0 -
2 0 0 
Figure 2. Residual urine volumes 
before and after incision. 
Pre-operative Post-operative 
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Urof lowmetr ic fo l low-up revealed an increase in maximum f low 
rate (MFR) in nearly all cases (Fig. 1). Voided volumes exceeded 150 ml . 
Pre-operatively, only 2 patients had a MFR above 15 ml/s. After endos-
copic surgery 20 of the 32 patients reached a MFR in excess of 15 ml/s. 
The average MFR before and after therapy was 7.1 ml/s (SD 4.79) and 
17.3 ml/s (SD 9.21) respectively. 
Post-operative measurementsof residual urinevolumesare given in 
Figure 2. Of the 14 patients w i th residual urine pre-operatively, 7 were 
able to void wi thout residual urine after surgery. The mean residual vo-
lumes before and after therapy were 441 ml (SD 308) and 139 ml (SD 
204) respectively. 
Hydronephrosis did not occur. Two out of four patients wi th 
bladder neck dyssynergia demonstrated detrusor instabil ity on cysto-
metry before surgery. One benefited f rom bladder neck incision, while 
the other remained unchanged. 
Retrograde ejaculation could be observed in 4 of the 11 men suit-
able for assessment. Post-operative haemorrhage of l imited degree occur-
red in one patient. 
Figure 3 shows good funnell ing of the posterior urethra after en-
doscopic prostatotomy (extended bladder neck incision). 
Figure 3. Post-operative voiding cystogram. 
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DISCUSSION 
In spite of our limited experience with the simple technique of tran-
surethral incision of the bladder neck with complementary prostatotomy, 
we prefer this procedure to the usual transurethral bladder neck resec-
tion. The latter technique sometimes leads to secondary sclerotic bladder 
neck contracture. The same can be said of prostatectomy and loop re-
section, especially for small prostatic enlargement. We have not yet seen 
secondary obstructive scarring of the bladder neck after endoscopic in-
cision. 
In the elderly high risk patient, even with moderate hypertrophy 
of the prostate, an extended bladder neck incision is to be preferred to 
the more traumatic and complicated resection or open operation. I ndeed, 
endoscopic incision takes only a few minutes and post-operative bleeding 
is rare. 
In young men with bladder neck obstruction or early prostatic 
enlargement, bladder neck incision deserves a place as a possible treat-
ment of choice, lengthy and sometimes inadequate medical treatment 
being the alternative. Incision is preferred not only for its simplicity and 
efficiency, but also because of the relatively low incidence of post-opera-
tive retrograde ejaculation. Turner-Warwick (1979) reported an incidence 
of about 15% when two incisions were made. If only a single incision 
was carried out, the incidence was reduced to 5%. However, in a prospec-
tive series of patients where unilateral bladder neck incision was used in 
order to prevent retrograde ejaculation, Moisey et al. (1982) were unable 
to reduce the 15% rate reported by Turner-Warwick (1979) following 
bilateral bladder neck incision. They reported an incidence of 16%. On 
the other hand, Jonas et al. (1979) observed retrograde ejaculation in 
only 7% of patients. However, it is not clear whether one, two or three 
incisions were used. In the present series, the number of men suitable for 
evaluation of this phenomenon is too small to allow valid conclusions, 
and the question of whether a single incision might reduce the percentage 
of retrograde ejaculation remains unanswered. 
The value of sophisticated urodynamic studies remains somewhat 
obscure when there exists clear evidence of bladder neck obstruction on 
the basis of clinical, endoscopic and f lowmetric examination. The precise 
nature of obstruction, either functional or anatomical, cannot be diag-
nosed only on the grounds of pressure and flow measurements. Here, 
videocystography may be of fundamental diagnostic value, like cystos-
copy. On the other hand, it may be clear that detrusor failure can only 
adequately be recognised urodynamically. 
Thus endoscopic extended bladder neck incision is a simple and 
effective method of relieving obstructive symptoms caused by bladder 
neck obstruction and early prostatic enlargement. It is perhaps especially 
useful in the young healthy and the elderly high risk patient. 
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Chapter IX 
Bladder Neck Incision in the 
Female: a Hazardous Procedure? 
K.P.J. Delaere, F.M.J. Debruyne and 
W.A. Moonen 
Department of Urology, St Radboud Hospital, Nijmegen, 
The Netherlands 
SUMMARY 
Anterior bladder neck incision was carried out in 32 female patients suf-
fering from difficult, mostly incomplete, bladder emptying. All patients 
underwent a full urodynamic investigation with voiding cystourethro-
graphy and endoscopy. Detrusor failure was observed in 20 patients; in 
the remainder, a mechanical iatrogenic bladder neck obstruction was 
held responsible for inefficient voiding. Twenty-eight patients (56%) 
benefited in some degree from the procedure. Six were submitted to a 
repeat incision and two of them developed severe stress incontinence 
later on. As the results are far from promising, intermittent self-catheteri-
sation may be proposed in some cases as an alternative to bladder neck 
incision for fear of incontinence. 
The urodynamic findings and the results of bladder neck incision, 
which are very different in the two sexes, are analysed. The poorer results 
in the female are presumably due to the decompensated state of the 
bladder, mostly responsible for incomplete bladder evacuation. 
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In women complaining of difficulties with voiding, detectable 
bladder outflow obstruction appears to be relatively uncommon (Farrar 
et al., 1975; Rees et al., 1975). This contradicts commonly held beliefs 
about obstruction at the bladder neck level in the female. This condition 
seems to be diagnosed and treated too often, perhaps because the diag-
nosis of bladder neck obstruction is made on the basis of a clinical analy-
sis alone. Moreover, the clinical presumption that bladder outlet obstruc-
tion in the female is the result of a bladder neck anomaly would be likely 
to be more than 95% inaccurate (Turner-Warwick, 1970; Farrar et al., 
1975). Therefore pressure and flow measurements with voiding cysto-
graphy are indispensable requisites in assessing the criteria of bladder 
neck obstruction. Voiding inefficiency may also be the result of detrusor 
failure or decompensation through which the bladder fails to open the 
bladder neck. 
In this study the indications, results and complications of endos-
copic bladder neck incision in 32 female patients are assessed. 
PATIENTS AND METHODS 
Thirty-two females with difficulty in emptying their bladders were stu-
died. Their ages ranged from 19 to 77 years (mean 48). The presenting 
symptoms are listed in Table 1. Twenty-nine patients (91%) had residual 
urine volumes ranging from 50 to 1000 ml, with an average of 398 ml. 
The remaining three patients had no residual urine at all. One third suf-
fered from recurrent urinary tract infections. There was a wide variety 
of causes of voiding dysfunction (Table 2). In the majority of patients 
(62.5%) there existed an acontractile detrusor. In this group 6 females 
had a neurological disorder, 3 had been operated upon for a meningo-
myelocele, 1 had multiple sclerosis, 1 had a cerebral tumour and another 
suffered from a prolapsed lumbar disc. The remainder (37.5%) acquired 
micturition problems as a result of previous vaginal surgery (nearly al-
85 
ways after anterior colporrhaphy). 
Each woman underwent full urodynamic investigation, including 
a urethral pressure profile and a cystometrogram with pressure and flow 
measurements. Voiding cystography was performed in an attempt to 
locate the precise site of the obstruction. Further routine investigations 
consisted of urethral calibration, cystoscopy and intravenous urography. 
The long-term follow-up varied from 6 to 44 months and sympto-
matic reassessment with measurement of residual urine volume, urine 
culture and uroflowmetry occurred approximately 3 months after sur-
gery. Generally, repeat urodynamic examinations were restricted to those 
patients who were considered for a second incision and who demonstrated 
unstable bladder contractions pre-operatively. 
Table 1 . Presenting symptoms 
Symptoms No. of patients 
Chronic retention of urine 29 
Poor urinary stream 19 
Hesitancy 14 
Frequency 13 
Recurrent urinary infection 12 
Nocturia 11 
Abdominal straining 10 
Urgency 6 
No spontaneous micturi t ion 6 
Urge incontinence 3 
Overflow incontinence 3 
Table 2. Indications for Endoscopic Bladder Neck Incision in the Female (n = 32) 
No. of (%) 
patients 
Detrusor failure 62.5 
• unknown origin (psychogenic?) 11 
• neurogenic 6 
• post-operative overdistension 2 
• after prolonged bladder distension 1 
Mechanical outf low obstruction 
(secondary bladder neck sclerosis) 37.5 
• after anterior vaginal repair 11 
• after sling suspension 1 
Operation 
A single endoscopic incision with a vertical diathermy electrode was 
made into the bladder neck at 12 o'clock. In general, the length of the 
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incision was limited to, at most, the proximal third of the urethra. Like 
Turner-Warwick et al. (1973), we prefer the so-called anterior bladder 
neck relaxation in order to avoid the risk of producing a vesicovaginal 
fistula. A urethral catheter is inserted for 24 h. 
RESULTS 
In б patients, all of them with detrusor failure, the initial incision seemed 
to be inadequate. They underwent repeat incision and the results are 
considered in the final symptomatic assessment of the total group (Table 
3). It seems that patients with mechanical bladder neck obstruction had 
better results than those with an acontractile bladder. About 56% of the 
patients benefited from the treatment. 
Table 3. Symptomatic Assessment After Bladder Neck Incision 
Cured 
Improved 
Unchanged 
Worse 
Atonic 
bladder 
3 
7 
7 
3 
20 
Bladder neck 
obstruct 
7 
1 
4 
0 
12 
¡on 
Total 
10 
8 
11 
3 
32 
(%) 
(31) 
(25) 
(34) 
(10) 
(100) 
Of the 12 patients with real outflow obstruction, 4 demonstrated 
uninhibitable detrusor contractions on cystometry. The cystometrogram 
changed to a stable pattern post-operatively in 2 of these patients. 
Recurrent urinary infection disappeared in half of the 12 patients 
who presented with infection prior to treatment. In these successful 
cases, pre-operative chronic retention was abolished. 
In the majority of patients (20 of the 32 studied), urodynamic 
examination disclosed no detrusor activity during efforts to induce mic-
turition. Only intrarectal pressure rises were recorded as a result of ab-
dominal straining, sometimes resulting in an interrupted poor urinary 
stream. 
In the remaining 12 cases, sufficiently strong detrusor contractions 
with associated impaired flow were registered. Detrusor pressures at 
maximum flow varied from 10 to 80 mmHg, with a mean value of 38 
mmHg (SD: 21, 34). The corresponding maximum flow rates ranged from 
3 to 24 ml/s and the mean flow rate was 10 ml/s (SD: 6, 21). Neverthe-
less, the ultimate value of pressure flow monitoring must be interpreted 
in relation to the data obtained by cystourethroscopy and cystourethro-
graphy, to determine whether or not there is bladder neck obstruction. 
The flowmetric changes after treatment are shown in Figure 1. The 
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average maximum f low rates before and after endoscopic incision were 
9 ml/s (SD: 7, 11) and 16 ml/s (SD: 7, 11) respectively. Before therapy, 
17 patients had maximum f low rates of less than 10 ml/s. After treatment 
this number fell to 12. 
Figure 1. Uroflowmetric assessment before and after bladder neck incision. 
Max flow r a t e -
imi /sec) 
4 0 
30 
2 0 
1 0-
o-1 
Pre-operative Post-operalive 
Post-operative measurements of residual urine volumes are given in 
Figure 2. The mean residual urine volumes before and after treatment 
were 398 ml (SD: 248) and 191 ml (SD: 217) respectively. The number 
of cases wi th chronic retention before therapy was 29 (91%) and this 
dropped to 20 (63%) after therapy. There was no difference between the 
atonic group and the obstructed group w i th regard to the decrease in 
residual volume post-operatively (Table 4) . 
Table 4. Residual Volume Before and After Incision 
Detrusor failure 
(n = 
Bladder 
(n = 
Total (r 
(%) 
20) 
neck obstruction 
12) 
i = 32) 
Pre-operative 
19 
10 
29 
(91) 
Post •operative 
13 
7 
20 
(63) 
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Figure 2. Pre-operative and postoperative residual urine volume. 
Residuai urine volume 
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Two patients who had undergone a second incision for detrusor 
failuredeveloped severe stress incontinence. Despite incontinencesurgery, 
the treatment was only moderately successful. 
DISCUSSION 
In the female, unlike the male, the bladder neck represents the primary 
sphincter mechanism for continence (Turner-Warwick, 1970, 1979). 
When an impaired balance between voiding forces and urethral resistance 
results in inefficient voiding in the female, it is usually the detrusor com­
ponent (decompensation) which is responsible. This is also in contrast 
with men, where usually an increased outflow resistance leads to difficult 
micturition. 
In the case of detrusor failure or relative outflow obstruction in 
the female, it is not easy to restore the equilibrium between detrusor and 
sphincter function by ablation of the bladder neck. This implies a delicate 
and precise procedure, because it is generally impossible to know how 
much relaxation of the bladder neck is required. Too extensive an incision 
may cause stress incontinence and an 'madequate incision will not restore 
the balance. There is, indeed, a very small margin between the inadequate 
and the incontinence-induced female bladder neck relaxation. This is 
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why the results of bladder neck incision for inefficient voiding in the 
female are generally less satisfactory than m the male, and why more 
complications are encountered. Our results m the female m this study, 
when compared wi th those m men (Delaere et al., 1983), have demon­
strated this. Note also the comparison of the f lowmetric results between 
men and women (Fig 3). 
Figure 3. Average flow rates in men and women, pre-operatively and post­
operatively.* 
Mean ' low rate — 
(ml/sec) 
20-1 
1 5 -
1 0 -
5 -
* Differences between pre-operatlve 
and post-operative means are both 
significant (t test, dependent sam­
ples, Ρ < 0 01) Standard errors ra­
ther than standard deviations are 
plotted 
Pre operative Postoperative 
о Female ( n = 32) 
α Male ( n = 3 2 ) 
In t ry ing t o prevent the troublesome compl icat ion of incontinence, 
some consideration must be given t o the urethral pressure profi le The 
extent of the incision wi l l be related m some way t o the functional ure­
thral length and urethral closure pressure. The pre-operative urethral 
pressure profi le is even more important when a second incision is deemed 
necessary. It is therefore better to be too prudent and t o be prepared t o 
repeat the procedure (Worth, 1980). However, when the length of the 
profi le is already shortened to such a degree after an initial unsuccessful 
incision, it is perhaps better not to repeat the procedure, and intermittent 
self-cathetensation may be indicated as a satisfactory alternative. Perhaps 
m some cases of detrusor failure w i t h coexistent decreased urethral resis­
tance, intermittent self-cathetensation is preferable t o a potential ly dis­
astrous bladder neck incision 
In our practice we are often confronted w i t h mictur i t ion disorders 
due t o bladder neck sclerosis and scarring after anterior vaginal repair 
(Delaere et al., 1979) It is our experience that m these cases of iatrogenic 
mechanical bladder neck obstruct ion, judicious incision is safer than 
when the primary defect is detrusor-onentated. 
Perhaps bladder neck incision, carried out under direct vision using 
a urethroplasty speculum, is more eff icient than the endoscopic proce-
90 
dure (Worth, 1980), but we have had no experience with this technique. 
This study constitutes a warning against embarking on bladder 
neck surgery in women without careful evaluation. However, once the 
diagnosis has been made, endoscopic incision should be done very 
cautiously, if necessary in two or more stages. 
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The influence of some 
pharmacological agents on the 
lower urinary tract 
Chapter X 
Urinary incontinence caused by 
prazosin 
Th. Thien, K.P.J. Delaere, F.M.J. Debruyne, 
R.A.P. Koene 
Departments of Medicine, Division of Nephrology, and Department of Urology 
St Radboud Ziekenhuis, University of Nijmegen 
The antihypertensive effect of prazosin is thought to result primarily 
from arteriolar smooth muscle relaxation and consequent peripheral 
vasodilatation.1 Soon after its introduction reports2 appeared of collapse 
due to postural hypotension ('first dose phenomenon'), suggesting an 
effect on the sympathetic nervous system. Recent experimental data 
favour the hypothesis that prazosin interferes with α-adrenoceptor func­
tion at the postsynaptic level.3 Our patient furnishes a new clinical argu­
ment for this hypothesis. 
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CASE REPORT 
A 58-year-old woman was referred because of hypertension (200/118 mm 
Hg).She had experienced repeated urinary tract infections after a pyelitis 
during pregnancy. A slight stress incontinence had remained after an 
operation for vaginal prolapse in 1967. Renal function was normal, and 
the intravenous urogram showed only slight pyelonephritic changes. 
Urinary cultures were negative. Because blood pressure control with 50 
mg chlorthalidone and 300 mg metoprolol daily was insufficient prazosin 
was added in a dose increasing in four weeks from 1.5 to 6 mg daily. On 
a dose of 3 mg she developed orthostatic complaints, and she collapsed 
once. After four weeks she complained of complete incontinence of 
urine, which started one to two hours after taking prazosin. One day 
after prazosin withdrawal the incontinence had disappeared. 
Urodynamic investigations were then performed before and during 
treatment with prazosin. Urethral closure pressure profiles were obtained 
by the catheter-withdrawal technique4 with an empty bladder in supine 
position, and with a full bladder (400 ml) supine and standing. These 
profiles give a measure for the maximum urethral closure pressure (maxi-
mum urethral pressure minus bladder pressure) and the functional ure-
thral length (distance where urethral pressure exceeds bladder pressure). 
To exclude urinary incontinence caused by 'unstable bladder' a cysto-
metrogram with pressure/fow analysis was also performed. 
In the three investigations before taking prazosin the maximum 
closure pressure and the functional urethral length were low-normal (see 
figure). The cystometrogram was normal. During micturition the maxi-
mum flow rate was 38 ml/sec (normal value for women 30 ml/sec). There 
was a detrusor contraction to 12 mm Hg without abdominal strain during 
micturition. After one week of prazosin (12 mg daily) the maximum 
closure pressure had decreased to abnormally low values. The height of 
the proximal part of the pressure profile had diminished, resulting in a 
substantial decrease of the functional urethral length (see figure). Again, 
95 
the cystometrogram was normal but the maximum flow rate was now 
higher (47 ml/sec), while the detrusor contraction had slightly decreased 
(8 mm Hg). One day after prazosin withdrawal results identical with 
those before treatment were obtained. 
Urethral pressure profiles before (upper panel) and during (lower panel) treatment 
with prozosin (12 mg daily). 
URETHRAL PRESSURE ( m m Hg) 
4 0 -
2 0 -
supme 
(empty bladder) 
supine 
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COMMENT 
The urinary incontinence in this patient was probably caused by prazosin. 
Withdrawal of the drug led to immediate disappearance of the symptoms 
on two occasions, while reinstitution was followed by complete inconti­
nence. The results of the urodynamic study suggest that this side effect 
is caused by α-adrenergic receptor blockade. The urethral pressure is de­
termined by the tonus of the smooth muscles of the proximal, pre-
sphincteric part of the urethra that are innervated by sympathetic nerves. 
Administration of phentolamine, a known α-adrenergic receptor blocker, 
decreases the maximal urethral closure pressure and the functional ure­
thral length. The latter decrease is caused by a pressure fall in the proxi­
mal urethra to the level of the bladder pressure.4 Identical changes were 
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observed in our patient during treatment with prazosin. Although nor-
mal people show differences in profiles with empty and full bladder, we 
found more impressive changes with full bladder. This might be related 
to the pre-existing stress incontinence in our patient. This minor dys-
function could have also caused the exaggerated reaction to prazosin. 
Several authors mention urinary frequency and sometimes incontinence 
as a side effect of prazosin.5 In our own group three out of 30 patients 
treated with prazosin developed urinary incontinence. One of them had 
already been operated on for this problem. Apart from the reported 
postural hypotension and the first dose phenomenon we found another 
clinical argument for the hypothesis that prazosin has a-sympathicolytic 
activity and is not a pure smooth-muscle relaxant. 
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Chapter XI 
The effect of some antihypertensive 
drugs on the urethral tone and 
continence 
K.P.J. Delaere, F.M.J. Debruyne and 
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Nijmegen, The Netherlands 
Translated from a publication in 'Tijdschrift voor Geneeskunde', 36, 
1141-1143(1980). 
ABSTRACT 
Antihypertensive drugs with alpha-sympathicolytic properties can de-
crease urethral pressure. As a result, stress urinary incontinence may 
appear, especially in women with suboptimal sphincter tone. Clinical and 
urodynamic findings ina number of female patients, treated with prazo-
sin, guanethidine or alpha-methyldopa, are presented. Attention is paid 
to the importance of measuring the blood pressure and enquiring into 
antihypertensive medication in every patient presenting with urinary in-
continence. 
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Drugs which interfere with or act upon the autonomic nervous 
system are often indicated for pulmonary, cardiovascular, gastrointestinal 
and urologica! dysfunctions. In general these drugs do not act selectively 
upon the parasympathetic or sympathetic innervation of the organ or 
sytem treated. Thus, side effects may be anticipated due to interactions 
with the autonomic innervation of other systems. 
It is known that parasympathetic depressants or anticholinergics, 
administered as bronchodilators or antispasmodics of the gastrointestinal 
tract, may cause acute urinary retention. Ephedrine hydrochloride, a 
sympathetic alpha-adrenergic agent which is often present in cough-
mixtures and nasal drops, can cause poor flow rates and even retention in 
patients with prostatic obstruction. It is therefore clear that in the assess-
ment of micturition problems accurate information on drug use is parti-
cularly important. 
For a good understanding of the neuropharmacological basis for 
the chemotherapy of dysfunctions of the lower urinary tract, it is ne-
cessary to be well informed about the function and innervation of the 
bladder and urethral sphincters. A synergic or coordinated function of 
bladder and urethra guarantees coordinated micturition and continence. 
If the coordination between bladder and sphincters is disturbed dysuria 
may occur, often with retention and/or incontinence. The autonomic 
innervation of the bladder is mainly parasympathetic. The trigone, the 
bladder neck and the proximal smooth urethral musculature are mainly 
controlled by the adrenergic system, and alpha-adrenergic activity pre-
dominates. The innervation of the periurethral striated muscle, forming 
part of the pelvic floor musculature, seems to be somatic (pudendal 
nerve). It can be stated that the act of micturition (detrusor contraction) 
is under parasympathetic influence, whereas the urethral resistance 
depends on alpha-sympathetic activity. 
Drugs with alpha-sympathicolytic activity will be used to decrease 
outlet resistance, through which a more effective micturition occurs. In 
some cases a stress incontinence will develop and also retrograde ejacu-
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lation may appear. Phenoxybenzamine (Dibenyl ine R ) is an alpha-adrener-
gic blocking agent often used in clinical urodynamics, for example, in 
patients wi th neurogenic bladder wi th excessively urethral resistance du­
ring m i c t u r i t i o n . 
Inasmuch as the antihypertensive effect of some antihypertensive 
drugs is due to their alpha-sympathicolytic activ ity, it is plausible that 
these antihypertensive agents might induce an easier mictur i t ion and 
even lead t o stress incontinence. 
One of the techniques for assessing the tone or the pressure w i t h i n 
the urethra is the urethral pressure prof i le (Brown and Wickham, 1969). 
Here the intraluminal pressure along the whole length of the urethra is 
recorded, f r o m the bladder t o the external meatus. Urof lowmetry is 
another investigation whereby (indirectly) some information about ure­
thral resistance is acquired. The f lowrate of the urinary stream is the 
amount of urine voided per t ime unit (ml/sec). This flow-rate is directly 
proport ional t o the detrusor contraction and indirectly proportional t o 
the urethral resistance. 
A n example of the influence of phentolamine (Regi t ine R ) , an 
alpha-blocker, on the intra-urethral pressure is depicted in figure 1. Ure­
thral pressure profiles were performed before and 2, 4 and 8 minutes 
after intravenous administration of 10 mg phentolamine. The maximum 
urethral closure pressure which amounted init ial ly t o 61 mm Hg, drop­
ped t o 41 mm Hg after 8 minutes. 
Figure 1 . 
URETHRAL PRESSURE-
( m m Hg) 
BEFORE AFTER 
2 mm 
PHENTOLAMINE 
IO mg ι ν 
AFTER 
4 mm 
AFTER 
θ mm 
0 10 20 30 40 Ö 10 20 30 40 ι r—τ 1
- 1 
0 10 20 30 40 О Ю 20 3 0 4 0 Urethral length (mm) 
Recently, a new antihypertensive drug, prazosin (Minipress R ), was 
clinically evaluated in the Department of Internal Medicine of the Sint 
Radboud Hospital, Nijmegen. Primarily, the antihypertensive effect of 
prazosin was thought t o result f r o m arteriolar smooth muscle relaxation 
and consequent peripheral vasodilatation. Soon, however, observations 
suggesting an effect on the sympathetic nervous system were made (Con-
stantine et al., 1973). In a group of 30 patients treated wi th prazosin, 
the fo l lowing complications were encountered: б patients developed 
orthostatic complaints and 3 patients became incontinent of urine (Thien 
and Koene, 1977). These phenomena were regarded as a consequence of 
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alpha-sympathicolytic act iv i ty. One of the patients who developed ur i­
nary incontinence, a 58 year old female, was fu l ly screened urodynami­
cally (Thien et al., 1978). The urethral pressure profiles during treat­
ment wi th prazosin showed a marked lowering of the urethral pressure 
and the f lowrate was increased. During treatment, this woman became 
extremely stress incontinent (sphincter weakness). The symptoms of 
incontinence disappeared one day after discontinuation of the drug. 
In another female aged 43 years, referred t o our Department of 
Urology because of a slight degree of stress incontinence, clinical exami­
nation revealed hypertension. The urodynamic study demonstrated a 
stable bladder f u n c t i o n . The urethral pressure profi le disclosed a maxi­
mum urethral closure pressure of 62 mm Hg. Treatment w i t h prazosin 
(Minipress R ) , 6 mg daily, was instituted. This therapy resulted in an 
aggravation of incontinence and at the same t ime she was troubled by 
postural hypotension. A urethral pressure profi le during prazosin treat­
ment showed a lowering of the urethral pressure and a shortening of the 
functional urethral length (Fig. 2). 
Figure 2. 
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With reference t o our experiences with prazosin, we assessed the 
influence of guanethidine ( lsmel ine R ) and alpha-methyldopa (Aldo-
m e t R ) , two antihypertensive drugs wi th known sympatholyt ic properties, 
on urethral pressure and continence in some patients. 
Three female patients who went for medical advice because of 
mictur i t ion complaints (and in whom hypertension was found) were 
screened urodynamical ly and consequently treated w i t h guanethidine, 25 
mg three times a day. Four weeks later, urological and urodynamic exa­
minations were again performed. T w o patients demonstrated a pronoun­
ced lowering of the urethral pressure. In one of them, the previous stress 
incontinence was dist inct ly worse. The urethral pressure profiles of this 
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woman, before and during treatment w i t h guanethidine, are depicted in 
figure 3. 
Figure 3. 
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Another female patient, aged 57 years and known t o have hyper­
tension, was treated w i t h alpha-methyldopa ( A l d o m e t R ) , 250 mg twice 
daily. This patient was continent before starting antihypertensive medi­
cation. The urethral pressure decreased slightly during treatment (Fig. 4 ) . 
A further female patient who consulted because of stress incontinence, 
had been treated for a long t ime w i t h alpha-methyldopa, 250 mg twice 
a day. Discontinuation of this drug, however, did not influence the uri­
nary incontinence and repetit ion of the urethral pressure profi le showed 
no change. 
Figure 4. 
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CONCLUSIONS 
1. It is recommended that the blood pressure be measured in each patient 
complaining of urinary incontinence. In the case of sphincter weakness 
with associated hypertension, medical treatment with alpha-adrenergic 
agents such as ephedrine hydrochloride should not be administered. 
2. In each patient with stress incontinence, one should check up on the 
possible use of antihypertensive drugs. If these have been prescribed, 
and the treatment consists of prazosin (MinipressR), guanethidine 
(lsmelineR) or alpha-methyldopa (Aldomet R ), it is strongly recommen­
ded that the drug be discontinued in order to assess to what extent the 
incontinence disappears. 
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Chapter XII 
The influence of ketanserin, a new 
serotonin antagonist, on bladder 
and urethral function 
K.P.J. Delaere, F.M.J. Debruyne and 
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From the Department of Urology, St Radboud University Hospital, 
Nijmegen, and the Department of Anesthesiology, Academic Hospital of the 
Free University, Amsterdam, The Netherlands 
ABSTRACT 
As it is known that serotonin or 5-hydroxytryptamine can enhance 
bladder act iv i ty, we studied urodynamical ly the effect of ketanserin, a 
serotonin antagonist, in seventeen patients, in the hope that this drug 
might be useful in treating unstable bladders. However, a relaxant effect 
on bladder contract i l i ty could not be demonstrated. On the contrary, a 
significant decrease of the urethral pressure was observed, suggesting 
that ketanserin might stil l have a possible role in promot ion of bladder 
emptying. The relaxant effect on the urethra, suggests some alpha-sym-
pathicolyt ic activity of ketanserin. 
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In recent years there has been an increasing interest in the phar-
macologic approach to the treatment of detrusor instability. Traditio-
nally, anticholinergic agents, ganglion blockers and musculotropic drugs 
have been used in order to enhance bladder capacity and control unin-
hibited detrusor contractions. However, none of these agents have been 
uniformly effective and their side effects have often constituted a limi-
ting factor. Moreover, their usefulness for long-term treatment remains 
questionable. Recently, we have obtained some experience with other 
drugs such as bromocriptine and indomethacin which, it has been sugges-
ted, have a relaxant effect on bladder tone and contractility1,2. Never-
theless, it seems that patients with motor urge incontinence do not profit 
greatly from either of these drugs3,4 . 
It has been suggested that many neurotransmitters can influence 
bladder and urethral function. Acetylcholine, norepinephrine and hista-
mine are known neurotransmitters with contractile effects on bladder 
muscle and their effects are mediated through specific receptors.5 Also 
prostaglandins have been shown to produce contractile responses on the 
detrustor muscle6·7. Nevertheless, we have not been able, using prosta-
glandin bJadder instillations, to promote bladder emptying in women 
with voiding dysfunctions.8 Another neurotransmitter which is said to 
enhance bladder activity is serotonin, or S-hydroxytryptamine5·9'10'11. 
And indeed, human studies have demonstrated the possible clinical value 
of serotonin activity for promoting bladder emptying.11 These observa-
tions prompted us to evaluate urodynamically the effect of the serotonin 
antagonist ketanserin (R 41 468, Janssen Pharmaceutica Belgium) on 
the lower urinary tract, anticipating a possible relaxant effect on bladder 
contractility. If such an effect were found, this compound might be use-
ful in treating patients with unstable bladders 
109 
PATIENTS A N D METHODS 
Seventeen patients w i t h varying mictur i t ion problems were studied: 12 
female (age-range of 21 t o 61 years, mean age 35 years) and 5 male pa­
tients (age-range of 14 t o 29 years, mean age 22 years). Each patient 
gave informed consent to participation in the study. They underwent a 
fu l l urodynamic examination, including f i l l ing and micturating cysto-
metrograms and a urethral pressure profi le, just before the intravenous 
administration of the drug. Five out of the 12 females studied demon­
strated uninhibitable detrusor contractions on cystometry, whereas all 
the males had normal bladder f u n c t i o n . Af ter 10 mg ketanserin had been 
administered as a slow (2 minutes) intravenous injection, repeated ure­
thral pressure profiles at 5, 10, 15 and 20 minutes were performed. Ap­
proximately 20 minutes after the injection,cystometrograms were carried 
out in 2 males and 11 females (5 w i t h unstable and б wi th stable blad­
ders). These 13 patients were all considered to-be suitable for further 
assessment. 
RESULTS 
The urodynamic data obtained f r o m the f i l l ing and voiding cystometry, 
before and 20 minutes after the administration of 10 mg ketanserin in­
travenously, are shown in Table 1. The differences in mean bladder ca­
pacity as well as mean bladder contraction were not significant (t-test 
for dependent samples, ρ > 0.05). Figure 1 shows the changes of the 
mean bladder contractions in the female group (bladder contraction at 
maximum f l o w rate in case of stable bladder, and amplitude of the unin­
hibited bladder contract ion in case of unstable bladder). In contrast, the 
changes of the average maximum f l o w rates (MFR) in the females w i t h 
stable bladder f u n c t i o n were significant (p < 0.01) (Fig. 2). This f inding 
might suggest a lowering of the urethral resistance. In the females w i t h 
unstable bladders, the cystometrogram did not change to a stable pattern 
after administration of ketanserin. 
Table I. Cystometrlc data before and after administration of 10 mg ketanserin intravenously. 
Mean Intravesical volume 
(ml) ± SE 
Before After 
Females 
— unstable bladder 
( n = 5) 
— stable bladder 
(n = 6 ) 
Males 
(n = 2) 
2 7 8 (± 74) 2 8 0 ( i 1 0 2 ) NS 
4 5 7 (± 6 3 ) 4 1 3 (± 6 8 ) NS 
5 1 0 2 5 0 
Mean bladder contraction 
(kPa) ± SE 
Before 
7 . 3 ( ± 
3.8 (± 
4.3 
1.9) 
0.6) 
After 
6.9 (± 1.4) NS 
2.9 (± 0.5) NS 
3.7 
Mean max. 
(ml/sec 
Before 
2 3 . 2 ( ± 4 
16.5 
7) 
f low rate 
) ± S E 
After 
28.3 ( ± 4 
22.5 
2) 
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Figure 1. Changes of the mean bladder 
contractions after ketanserin injection 
in 11 females (p > 0.05; NS) 
DETRUSORCONTRACTION 
before and alter KETANSERIN (IO mg ι ν) 
Belore After 
Δ η = 6 , stable bladder 
A η= 5 , unstable bladder * η =11 
Figure 2. Changes of the maximum flow 
rate after ketanserin injection in 6 fe­
males with stable bladder (p > 0.01; S) 
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Table I I . Effect of ketanserin (10 mg IV) on max. urethral closure pressure (kPa) in 
5 males. 
Mean 
SE 
Before 
14 00 
9 07 
9 60 
11 33 
10.13 
n = 5 
10 83 
0 88 
5 
4 47 
6.40 
9.60 
12 00 
3.07 
n = 5 
7.11 
1.64 
NS 
10 
10 67 
6.67 
7.73 
10 13 
3 20 
n = 5 
7 68 
1 34 
S 
( P < 0 . 1 ) 
15 
6 40 
— 
10 00 
11.07 
2.93 
n = 4 
7 60 
1 85 
NS 
20 minutes 
9.60 
— 
— 
— 
2.13 
n = 2 
5.87 
3.74 
Analysis of the urethral pressure profiles m 5 males showed only 
a slight significant decrease (p < 0.1) of the mean maximum urethral 
closure pressure, 10 minutes after administration of ketanserin, as com­
pared with the pre-treatment values (Table I I ; Fig. 3). In the 12 females 
studied, there was a highly significant decrease of the urethral closure 
pressure after 5 minutes (p < 0.01), 10, 15 and 20 minutes (p < 0.05) 
(Table I I I , Fig 3). The pressure decrease was most pronounced m the 
females after 15 minutes and amounted to 49 per cent. Also the diffe­
rences m functional urethral length, assessed in the female group only, 
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were significant after 5 minutes (p < 0.01) and 20 minutes (p < 0.05) 
(Table IV ; Fig. 4) . The external urethral sphincter electromyography 
act ivi ty did not show any obvious changes as a result of ketanserin ad-
ministrat ion. 
Table I I I . Effect of ketanserin (10 mg IV) on max. urethral closure pressure (kPa) in 
12 females. 
Mean: 
SE: 
Before 
4.27 
11.47 
7.47 
5.87 
4.00 
5.07 
8.53 
12.40 
5.33 
8.40 
5.47 
5.33 
n = 12 
6.97 
0.79 
5 
— 
6.67 
3.33 
— 
— 
— 
3.60 
8.27 
3.33 
5.33 
4.13 
1.07 
n = 8 
4.47 
0.79 
S 
( p < 0.01) 
10 
— 
6.93 
3.60 
— 
— 
3.07 
4.40 
7.33 
3.60 
3.87 
3.60 
0.93 
n = 9 
4.15 
0.65 
S 
( p < 0.05) 
15 
— 
— 
— 
1.60 
2.80 
— 
4.00 
7.60 
3.73 
4.27 
— 
1.33 
n = 7 
3.62 
0.79 
S 
( p < 0.05) 
20 minutes 
2.40 
— 
— 
— 
— 
— 
4.53 
7.47 
3.20 
4.53 
— 
2.13 
n = 6 
4.04 
0.80 
S 
( p < 0.05) 
Table IV. Effect of ketanserin (10 mg IV) on functional urethral length (mm) in 12 
females. 
Mean: 
SE: 
Before 
36 
35 
26 
35 
30 
25 
35 
25 
36 
42 
35 
31 
n = 12 
32.58 
1.51 
5 
— 
33 
23 
— 
— 
— 
30 
22 
32 
40 
34 
25 
n = 8 
29.87 
2.18 
S 
( p < 0.01) 
10 
— 
36 
23 
— 
— 
32 
30 
23 
33 
37 
35 
23 
n = 9 
30.22 
1.93 
NS 
15 
— 
— 
— 
38 
31 
— 
32 
21 
33 
34 
— 
26 
n = 7 
30.71 
2.11 
NS 
20 minutes 
35 
— 
— 
— 
— 
— 
32 
21 
31 
34 
— 
26 
n = 6 
29.83 
2.18 
S 
( p < 0.05) 
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Figure 3. Changes of the mean maximum urethral closure pressure (UCP) after ke· 
tanserin, in female patients (unshaded blocks) and male patients (shaded blocks). 
* : significant differences compared with baseline value. 
* * * : highly significant difference compared wi th baseline value. 
UCP 
kPa 
15 г 
10 
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Figure 4 . Changes of the mean functional urethral length (FUL) after ketanserin, in 
female patients. 
* 
* : Highly significant difference compared with baseline value. 
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COMMENT 
It has been speculated from the results of animal experiments that 
5-hydroxytryptamine (5-HT) or serotonin elicits bladder contrac-
t ions 9 , 1 0 , 1 1 · 1 3 . The excitatory action of 5-HT in the urinary bladder has 
been ascribed to serotonin receptors in the autonomic bladder ganglia as 
well as in the bladder smooth muscle.10 Inasmuch as the bladder contrac­
tion produced by 5-HT appears to be resistant to certain 5-HT antago­
nists and spasmolytic drugs, the possibility of the existence of more than 
one kind of 5-HT receptor has been suggested.9 Saum and de Groat sho­
wed that the administration of 5-HT to cats produced a bimodal contrac­
tion of the bladder: an initial transient bladder contraction which could 
be correlated with excitation of the bladder parasympathetic ganglia, and 
a secondary more prolonged response which presumably was due to 
direct stimulation of the bladder smooth muscle.10 
Recently, two different types of serotonin receptors have been 
proposed: the 5-ИТі receptor for itself, and the 5-HT2 receptor for 
spiperone.14 It is not known which of these receptors are present in the 
bladder muscle, the urethra and the bladder ganglia, or how the different 
receptors might be distributed. 
Arbitrarily, we have studied urodynamically the effect of a strictly 
selective antagonist of serotonin, namely ketanserin (R 41 468, Janssen 
Pharmaceutica Belgium) on 5-HT2 receptors. This drug is a new quinazo-
line derivative. All other known serotonin antagonists act both on 5-HT, 
and 5-HT2 receptors. The results of the urodynamic examinations did 
not show any changes in bladder contractility after ketanserin admini­
stration. From this, one might conclude that 5-HT2 receptors are not 
located in the bladder muscle, and that ketanserin seems not to have 
anticholinergic properties. However, the fact that a significant decrease 
of urethral pressure was demonstrated allows us to suppose the existence 
of 5-HT2 receptors in the bladder neck and urethra. It is not clear from 
the present investigation whether these receptors are present in the 
smooth or the striated muscles of the urethral wall. The relaxant effect 
on the urethra, suggests some alpha-sympathicolytic activity of ketanse­
rin. 
From the results of our study we believe that ketanserin can be 
used as a drug to decrease urethral resistance in patients with outflow 
obstruction due to prostatic enlargement or bladder neck dyssynergia. 
Alpha-blockers such as phenoxybenzamine, which are often employed to 
relax the urethra, often produce severe side effects (postural hypoten­
sion). Ketanserin, which is tolerated very well, may be an alternative to 
phenoxybenzamine. 
It can be concluded that ketanserin, a 5-HT2 receptor blocking 
agent, is not able to reduce bladder activity, as previously expected. On 
the contrary, however, ketanserin can produce a marked decrease in the 
urethral pressure, suggesting a possible alpha-sympathicolytic activity. 
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Further investigations seem therefore te be warranted with oral ketanse-
rin in order to assess its possible clinical value in promotion of bladder 
emptying as a result of reduction of urethral resistance. 
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Part IV 
Iatrogenic disturbances of the 
lower urinary tract 
Chapter XIII 
Anterior Vaginal Repair, Cause of 
Troublesome Voiding Disorders? 
K.P.J. Delaere, W.A. Moonen, F.M.J. Debruyne, 
H.G.E. Michiels and G.A.M. Renders 
Department of Urology, St Radboud University Hospital, Nijmegen 
ABSTRACT 
Clinical experience and urodynamic observations in 85 female patients 
with voiding disorders after anterior vaginal repair are presented. Iatro-
genic or persistent urinary stress incontinence (72%), irritable trigone 
syndrome (48%), bladder outlet obstruction (40%), unstable bladder 
(25%) and recurrent cystitis (23.5%) were the most frequent findings. 
Also, 5 cases of urogenital fistula and 2 cases of loss of a great part of 
the urethra were noted. Attempts to cure these complications with dif-
ferent pharmacologic agents and/or surgical methods were often dis-
appointing. 
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In most cases of genital prolapse a more or less significant degree 
of cystocele and/or rectocele may occur. However, cystocele may be 
present without any prolapse of the uterus. About 25% of genital pro­
lapses are associated with stress incontinence.1 I η isolated cystocele stress 
incontinence may appear in more than 50%.2 In gynecological practice, 
cystocele with or without associated urinary stress incontinence, is 
mostly managed by anterior colporrhaphy. Some gynecologists prefer in 
cases of pure stress incontinence, without significant prolapse of the 
vaginal vault, a vaginal approach to restore the impaired sphincter mecha­
nism. Because of the frequent association of uterine prolapse with cysto­
cele and/or rectocele, vaginal hysterectomy is often completed with ante­
rior and/or posterior colporrhaphy. In a series of 1,000 vaginal hysterec­
tomies, Copenhaver3 noted 690 associated anterior repairs. In the urolo­
gica! as well as in the gynecological literature, contributions about urolo­
gica! complications after prolapse operations are rare, and often limited 
to an enumeration of urogenital fistulae and/or urinary tract infections 
in the immediate postoperative period3"5. Iatrogenic or persistent urinary 
stress incontinence ¡soften not reported at all; also, detrusor and bladder 
neck dysfunctions are hardly described. The seriousness of some of these 
intractable complications suggests a reconsideration of the indication for 
anterior vaginal repair. 
The purpose of this paper is to report our experience of urological 
complications due to one or more previous anterior colporrhaphies. The 
pathophysiological phenomena and possible therapeutic modalities will 
be discussed. In many of our cases, these urological disorders were either 
hard to cure or incurable, in spite of several medical and/or surgical 
treatments. 
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CLINICAL OBSERVATIONS 
During 1975 and 1976, 85 female patients with one or more anterior 
vaginal repairs in their history consulted us for voiding disorders. 
Urological evaluation included history, physical examination, 
urinalysis, excretory urography, voiding cysto-urethrography, cysto­
metry with pressure/flow analysis, urethral pressure profile and cystos­
copy. The patients ranged in age from 35 to 78 years. At the time of 
prolapse operation, 50 patients (59%) complained of urinary stress in­
continence, 5 patients (6%) probably had an unstable bladder and 3 pa­
tients (3.5%) had recurrent urinary tract infections. The other subjects 
had no urological problems before vaginal surgery. Most cases were re­
ferred to us for advice and management several months or even years 
after the initial gynecological intervention. It is noteworthy that 19 pa­
tients (22%) underwent 2 or more vaginal operations. Moreover, 3 pa­
tients were operated б times vaginally. Altogether 121 prolapse opera­
tions were performed in the 85 females studied. 
Many patients had been operated upon by the same gynecologists, 
which leads us to suspect that their indication might have been doubtful 
and their surgical technique insufficient. The reasons for urological advice 
are summarized in table I. It is notable that symptoms of incontinence, 
urgency, frequency, and dysuria predominate. Especially after multiple 
prior prolapse interventions, more of these symptoms occurred together 
in the same patient in a more pronounced degree. 
Table I. Urological symptoms after anterior vaginal repair 
Number of patients 85 100 
Incontinence 74 87 
Acquired 16 
Unchanged 38 
Increased 11 
Diminished 9 
Urgency 56 66 
Dysuria 40 47 
Nocturia 39 46 
Frequency 34 40 
Strangury 12 14 
Suprapubic tenderness 8 9 
The different symptoms and disorders will be analyzed successively 
and elucidated where possible by means of the pathophysiological phe­
nomena. 
Incontinence (table II) 
As mentioned above, 16 of these females were continent before the pro-
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lapse operation. 
We assume that at least 15 unstable bladders were the direct result 
of the vaginal repair. In 5 females the detrusor instability apparently 
existed already. In the remaining б cases the time of origin is uncertain. 
Concerning the etiology of bladder instability a correlation with bladder 
outlet obstruction could not be found. Moreover, a relief of the outlet 
obstruction did not convert to stability. In 5 females, however, there 
may well be a relation to urinary tract infections. In stress incontinence 
it was usually not possible to state whether the sphincteric mechanism 
was still intact, or the bladder neck and the urethral musculature dama­
ged. However, in iatrogenic stress incontinence, we assert that surgical 
trauma of the urinary sphincters or postoperative urethral fibrosis do 
not allow normal sphincteric function. 
Table II. Cause of urinary Incontinence 
η % 
Number of patients 74 100 
Sphincter weakness 46 62.2 
Unstable bladder 11 15 
Sphincter weakness and unstable bladder 15 20 
Vesicovaginal fistula 1 1.4 
Ureterovaginal fistula 1 1.4 
Urgency (table III) 
In analyzing this symptom, we make a differentiation between motor 
urgency and sensory urgency.6 Urgency in case of detrusor instability is 
called motor urgency. When there is no occurrence of uninhibited detru­
sor contractions on cystometry, urgency is determined as sensory and 
may be the result of inflammatory reactions such as cystitis or trigonitis. 
In most cases of sensory urgency or irritable trigone syndrome following 
anterior vaginal repair, we assume that it is due to irritation of the trigone 
and proximal urethra by the scar in the anterior vaginal wall. Here vagi­
nal examination is mostly sensitive or painful and dyspareunia is coexis­
ting. Frequency and nocturia are mostly associated both with sensory 
and motor urgency. 
Table III. Differentiation of urgency 
η % 
Number of patients 56 100 
Sensory urgency 34 60.7 
Motor urgency 15 26.8 
Sensory and motor urgency 7 12.5 
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Prostatism 
Another mictur i t ional disorder is the entire complex of symptoms of 
straining, hesitancy, diurnal frequency, nocturia, urgency and dribbl ing. 
In our series, 34females (40%) complained of this embarrassment, which 
we call 'prostatism post prolapsum'. Bladder outlet obstruct ion, usually 
located at the bladder neck, is the common cause of these obstructive 
symptoms. We believe that too rigorous and injudicious vaginal dissec-
t ion , especially in the anterior midline too close to the urethra, causes 
laceration and damage to the vesicourethral junct ion and the urethral 
musculature. Consequently, stress incontinence due to sphincteric trau-
ma, as well as obstruct ion wi th prostatism due to bladder neck sclerosis 
Figure 1. The mechanism of prostatism associated with incontinence. 
A. Normal bladder neck at rest and during micturition. 
B. Stress incompetent bladder neck at rest and obstructive bladder neck during mic-
turition. 
closed bladder neck 
at rest 
wide open bladder neck 
during micturition 
scarred 
bladder neck 
bladder neck 
not entirely closed at rest 
bladder neck 
not entirely opened 
during micturition 
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and/or urethral fibrosis and scarring, may occur together. In 26 of the 
34 patients with obstructive urinary symptoms, we found an associated 
stress incontinence. In 9 of these 26 females additional problems of uri­
nary retention or residual urine also existed. We presume that combina­
tion of prostatism and stress incontinence can be elucidated as follows. 
The proximal urethral musculature which represents the most important 
sphincteric mechanism is damaged and scarred by one or more previous 
surgical attempts by vaginal approach. On the one hand the bladder neck 
becomes sclerotic and rigid, and does not close properly at rest. Hence, a 
urinary incontinence results. On the other hand, the scarred bladder neck 
opens slowly and incompletely during micturition, and with great diff i­
culty. Hence, an insufficient urinary flow results. We compare such stress 
incompetent and obstructive bladder neck with a 'rustly lock', which 
does not shut entirely and is unable to open entirely either (fig. 1). 
Cystitis 
Recurrent infection of the lower urinary tract occurred in 20 of the 85 
subjects studied (23.5%). We suggest that an impaired washout during 
micturition, due to the postoperative altered morphology of the urethra, 
may be one of the most important causes. Nevertheless, in some cases 
urinary retention was found to be an evident cause in the genesis of cy­
stitis. Different and prolonged chemotherapeutical courses were hardly 
able to cure the infections. 
Urogenital Fistulae 
In our series we encountered 5 urogenital fistulae (6%), namely 3 urethro­
vaginal, 1 vesicovaginal and 1 ureterovaginal fistula. The urethral fistulae 
were located once in the midurethra and twice more distally, not leading 
to incontinence and not requiring therapy. The urethral pressure profile 
in the case of urethrovaginal fistula shows an area of pressure decrease 
corresponding to the fistulous opening (fig. 2). These so-called major 
complications could perfectly be resolved by surgical management. 
Figure 2. Urethral pressure profile in patient with urethro-vaginal fistula. 
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Urethral Defect 
2 patients with multiple previous prolapse operations presented a practi­
cally totally destroyed urethra and scarred microvagina. Only the proxi­
mal third of the urethra was left and even this third was insufficient, re­
sulting in continuous urinary leakage. 
MANAGEMENT 
Urological complications following anterior vaginal repair are not easy to 
resolve and often intractable. The results of medical as well as surgical 
managements are mostly disappointing. The most annoying complaints 
which are to be solved are sensory urgency, prostatism with or without 
urinary incontinence and recurrent cystitis. In our study of 85 females 
who presented these complications, 62 underwent one or more surgical 
treatments, sometimes combined with drug therapy. Altogether 121 
urological interventions were performed (table IV). 
Table IV. Surgical treatment In 62 patients 
Intervention η 
Number of patients 62 
Number of interventions 121 
Suprapubic colpourethropexy 42 
Internal urethrotomy (Otis) 20 
TUR bladder neck 19 
Urethral dilatation 12 
Prolonged bladder distension 11 
Bladder neck incision 9 
Cystostomy and closure of the urethra 2 
Ureteroileocutaneostomy (Bricker) 2 
Colpopromontoriopexy 2 
Closure of vesicovaginal fistula 1 
Ureteral reimplantation 1 
DISCUSSION 
The management of urinary incontinence represents a main problem for 
the urologist. Our procedure of choice in persistent and iatrogenic stress 
incontinence is a suprapublic colpourethropexy according to Marshall et 
al.7 or Burch.8 If stress incontinence is associated with bladder outlet 
obstruction, we still propose suprapubic colpourethropexy, since this 
operation, when perfectly done, will not create any additional obstruc­
tion.9 Exceptionally, relief of outflow obstruction is necessary after­
wards. Failures of suprapubic colpourethropexy are probably due to 
previous traumatized urethral sphincters and surrounding fibrosis. In 
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these failures we recommend the abdominovaginal approach for colpo-
urethropexy, using a sling of rectus fascia. From this procedure some 
success may be anticipated as a result of extrinsic urethral compression. 
The management of the so-called intractable incontinence when 
different previous attempts of repair have failed, still poses insurmoun­
table problems. Some females feel great practical relief with an indwel­
ling catheter. Often one is committed to urinary conduit diversion. We 
have recently achieved a satisfactory result in performing sling suspen­
sion with an intentionally too strongly tightened sling, with the purpose 
of creating completed urethral obstruction. Afterwards intermittent cat­
heterization offers an acceptable alternative. Another resolution in the 
case of intractable dysfunctional lower urinary tracts, can be found in 
closure of the urethra combined with permanent suprapubic cystostomy. 
For the relief of prostatism, transurethral resection of the bladder 
neck or an anterior relaxation of the bladder neck can be indicated.10 
These procedures must be performed with caution for fear of urinary 
leakage. The troublesome condition of sensory urgency as a result of 
vaginal surgery, remains one of the most discouraging tasks for the uro­
logist. Different therapies can be applied, such as internal urethrotomy 
and urethral dilatation. With the administration of α-adrenolytic agents 
like ergotamine tartrate or phenoxybenzamine, one can try to inhibit the 
hypersensitivity of the trigone and proximal urethra. Other available so­
lutions are electrocauterization of the trigone or infiltration of the trigone 
and vaginal scar with triamcinolone. However, the overall results of these 
methods were poor. 
In the management of unstable bladder, we resort to common re­
medies such as propantheline bromide, emepronium bromide or f lavoxate 
hydrochloride. In resistant cases we perform a prolonged bladder disten­
sion1 1 , 1 2. In cases of bladder instability associated with bladder outlet 
obstruction, previous relief of the obstruction did not revert to a stable 
pattern. We noted relief of the symptoms due to unstable bladder in 
some cases after chemotherapeutic treatment of the accompanying uri­
nary infection. 
In the few patients with persistent pronounced cystocele, causing 
unsatisfactory voiding in a bent position with urinary retention, we per­
formed with good results, a transperitoneal colpopromontoriopexy as an 
alternative to a repeated prolapse operation. 
In agreement with gynecologists, we operate on a vesicovaginal 
fistula vaginally. A ureterovaginal fistula, often complicated by obstruc­
tive hydronephrosis, requires ureteral reimplantation preferably via the 
transperitoneal approach. 
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CONCLUSION 
It remains a difficult question to us to assess exactly the incidence of 
urological disorders after vaginal prolapse surgery, but the fact that 
about 1 patient every week attends our urological department, leads us 
to assume that such complications are not uncommon at all. This is not 
so surprising if one remembers that surgical procedures at the anterior 
vaginal wall, in the region of the trigone, the bladder neck and the urethra, 
can damage and cause cicatricial fibrosis of the very delicate structures 
responsible for micturition and continence. On the other hand, one must 
make some reflections on the indication for anterior vaginal repair. We 
cannot part with the impression that some gynecologists are too inclined 
to correct surgically moderate cystocele which often or even mostly does 
not give any discomfort. We think that too many urogenital complaints 
are ascribed to the presence of a cystocele. Besides, it may be that gyne-
cologists who are not urologically minded, are insufficiently aware of the 
dangers in dissecting too close to the urinary sphincters. In the case of 
pure stress incontinence, we agree with Tanagho9 that suprapubic vesi-
courethropexy is the only correct one. If stress incontinence is associated 
with large cystocele, we recommend a colpopromontoriopexy combined 
with some sutures placed laterally in the anterior vaginal wall and at-
tached to Cooper's ligament. 
In our experience, the apparently minor complications of sensory 
urgency, recurrent cystitis and prostatism are mostly quite intractable, 
whereas apparently major complications such as urogenital fistulae are 
usually easy to cure effectively. 
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Comments and conclusions 
Part I. Therapeutic aspects of the unstable 
bladder. 
Chapters I, II and I I I . 
The treatment of patients wi th motor urge incontinence is usually medi-
cal. In general, the overall results are rather disappointing and this can 
also be concluded f rom our open trials wi th flavoxate hydrochloride 
(UrispasR), bromocript ine (ParlodelR) and indomethacin ( lndoc id R ) . 
We have to confess that we were sometimes slightly frustated because of 
the absence of the anticipated results, and because we were not always 
able to reproduce the favourable results of some other investigators. 
Here the question arises how fair and correct scientific data should be 
reported. Otherwise, it is a wel l-known fact that many preliminary re-
ports about new treatments give mostly very promising results. But fur-
ther reports often disclose all the facts of the case or, in other words, 
yield less good results. 
What are the reasons for the high percentage of non-responders to 
drug treatment? 
First of al l , neither the aetiology of the unstable bladder in which 
an organic cause has been excluded nor the pathophysiology of the con-
di t ion seem to be understood. Therefore, medical treatment is mainly 
for the relief of the symptoms and is particularly directed to suppression 
of parasympathetic act iv i ty, in spite of the fact that there is really no 
evidence that the cause of idiopathic detrusor instabil ity is due to para-
sympathetic overactivity. Hence, the lack of significant benefit f rom 
anticholinergic drugs is to be expected. 
Moreover, it becomes more and more clear that a certain psycho-
somatic origin of this condit ion can not be denied (Frewen, 1972; Hafner 
et al., 1977; Frewen, 1978). In a study of 40 female patients wi th un-
stable bladders, an emotive or psychogenic factor was discovered in all 
of them (Frewen, 1978). This may probably explain the encouraging re-
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suits of psycho-medical treatment,such as bladder retrainingand biofeed-
back training (Frewen, 1978; Mahady and Begg, 1981; Cardozo et al., 
1978; Jarvis, 1982; Fanti et al., 1981 ; Pengelly and Booth, 1980; Elder 
and Stephenson, 1980). Unfortunately, we have had no experience yet 
with these methods. 
Another piece of evidence that makes plausible an emotive preci-
pitating factor which could be related to the onset of symptoms and to 
the fact that some patients may get better on their own, is the finding 
that the effects of placebo have proved equal or superior to those of 
'active' drugs such as emepronium bromide or flavoxate (Meyhoff et al., 
1983). Even hypnotherapy has been proved to be effective for inconti-
nence due to idiopathic detrusor instability (Freeman and Raxby, 1982). 
Besides, we have hitherto no clear idea of the natural history of this con-
dition. The course of the symptomatology is often characterised by 'ups 
and downs'. It is therefore not always possible to indicate whether an 
improvement is really due to the drugs used, or to spontaneous evolution. 
Important additional information concerning drug therapy for the 
unstable bladder requires further attention. In spite of the widespread 
oral use of anticholinergic and other musculotropic drugs such as pro-
pantheline bromide (ProbanthineR ), flavoxate hydrochloride (UrispasR ), 
emepronium bromide (CetiprinR) and imipramine hydrochloride (To-
franil" ), it is useful to be informed about the urodynamic changes when 
these drugs are administered parenterally. It may seem surprising that 
intravenous flavoxate and intramuscular imipramine fail to produce sig-
nificant changes at 10 or 30 minutes (Cardozo and Stanton, 1979; Briggs 
et al., 1980). We also repeated the cystometric recordings in 5 patients 
with unstable bladders, 15 minutes after the intravenous injection of 200 
mg flavoxate, and ascertained no effect (unpublished data). Nevertheless, 
some authors claim that intravenous flavoxate does influence bladder 
capacity and intravesical pressure (Pedersen, 1977; Jonas et al., 1979). 
Melchior found that oral flavoxate showed improvement of the subjec-
tive symptoms, but not of the urodynamic finfings (1983). Briggs et al., 
evaluated the effect of flavoxate in elderly patients. No consistent drug 
effect could be detected cystometrically and incontinence was unchan-
ged clinically (1980). Emepronium bromide, a ganglion blocker, ought 
also to be effective when given intramuscularly (Ritch et al., 1977; Eke-
land and Sander, 1976; Cardozo and Stanton, 1979). However, another 
study on intramuscular emepronium in elderly patients, confirms that 
this drug is ineffective in increasing bladder capacity in subjects wi-r. 
small hyperreflexic bladders (Perera et al., 1982). As it is known that 
quaternary ammonium compounds, such as emepronium, are absorbed 
poorly from the gastrointestinal tract, the oral use of emepronium should 
also be questioned (Vessman et al., 1970). Indeed, it has been shown 
that oral emepronium is ineffective, and that there is no significant dif-
ference between the effect of emepronium and that of placebo (Ritch 
et al., 1977; Williams et al., 1981 ; Walter et al., 1982). The efficacy of 
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intravenous propantheline, a synthetic analogue of atropine, and its abi-
lity to suppress uninhibited bladder contractions, has been well documen-
ted (Gregory et al., 1974; Benson et al., 1977; Finkbeiner étal., 1977). 
Patients who respond to parenteral medication should have a favourable 
response to the orally administered drug (Blaivas et al., 1980). 
Our overall results with three commonly used drugs are as follows: 
(1) of the 121 patients with unstable bladders treated with propanthe-
line, 35 reported more or less subjective improvement (28,9%); (2) of 
the 121 patients treated with emepronium, 42 experienced some impro-
vement (34,7%); (3) of the 97 patients treated with flavoxate, 28 showed 
improvement (28,9%) (Delaere, 1980). We would emphasise again that 
these results should be interpreted in the light of the above mentioned 
considerations. 
With great regularity, new drugs are recommended which are clai-
med to have a promising therapeutic role in the treatment of bladder in-
stability. Such was also the case with bromocriptine and indomethacin. 
From our results, however, we were inclined to quash this budding enthu-
siasm. And subsequent reports confirmed also the clinical uselessness of 
bromocriptine for detrusor dysfunctions (Abrams and Dunn, 1979; 
O'Boyle and Parsons, 1979; Cardozo and Stanton, 1980). One of the 
hypothetical modes of action of bromocriptine on bladder function, 
might be due to its property as a dopamine receptor stimulant. Recently, 
the effect of intravenous metoclopramide (PrimperanR), a dopamine 
receptor antagonist, was studied urodynamically. However, no signifi-
cant change was found in detrusor reflex activity and in urethral pressure, 
suggesting that dopamine receptors are not important in vesicourethral 
function (Vaidyanathan et al., 1980). And what is still worse, bromo-
criptine has been suggested as the causative factor for developing urinary 
incontinence probably due to detrusor instability (Gonathan and Calne, 
1980). Indeed, a recent in vitro study has demonstrated that bromocrip-
tine has both a direct stimulating effect on the detrusor muscle, and an 
anticholinergic effect. Because of the relatively weak anticholinergic ef-
fect, the net effect on the detrusor is to increase the tone (Ron et al., 
1980). Besides, bromocriptine appears to have a relatively powerful 
alpha-adrenergic blocking effect on the human prostatic muscle, explai-
ning its possible beneficial effect on obstructive symptoms in case of 
prostatic hypertrophy (Shapiro et al., 1980). 
Our experiences with indomethacin were (also) negative. In recent 
years, no additional clinical reports on this subject have been published. 
However, animal experiments have provided further evidence that indo-
methacin significantly increases the treshold micturition volume and re-
duces the maximum intravesical pressure (Khalaf et al., 1981). The mode 
of action would be mediated through either prostaglandin synthetase 
inhibition or its calcium antagonistic responses (Northhoven, 1971). But 
in any case we are once again confronted with the discrepancy between 
experimental physiological data and clinical findings. 
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Chapters IV and V. 
Our long-term results of prolonged bladder distension are poor in patients 
wi th unstable bladders who have not responded to prior medication. The 
high percentage of relapse after an init ial improvement is striking. Fur-
thermore, the procedure is very t imeconsuming and not altogether free 
f rom severe complications such as bladder rupture. A l l in all, we have 
decided that it is better not to recommend bladder distension for detru-
sor instabil i ty. During the past three years, no important contr ibutions 
have been presented on this type of treatment. 
It may noted in passing that our experiences wi th bladder transec-
t ion in about 25 patients after conventional non-operative treatment had 
failed, are also far f rom promising (unpublished data). In the meantime, 
we have abandoned this technique. Af ter all this, we are somewhat con-
fused that there is still in the (European) literature some opt imism in 
respect to this operation, designed as a denervation procedure (Essenhigh 
and Yeates, 1973;G¡bboneí al., 1973; Hindmarsh et al., 1977; Janknegt 
étal., 1979 ;Mundy , 1983). 
In the United States, l i t t le enthusiasm has been generated for sur-
gical intervention in urge incontinence. The existence of autonomic neu-
rones wi th in the bladder wall should explain why it is surgically impossi-
ble to denervate the detrusor (Gosling and D ixon , 1975). 
A discussion on the roles of augmentation cystoplasty, selective 
sacral neurectomy, electrical st imulat ion and subtrigonal phenol injec-
t ion wil l not to be held here. 
It is concluded that, despite much research and many therapeutic 
attempts, the problem of motor urge incontinence still remains a major 
one. One of the important things we have learnt f rom our clinical studies 
concerning detrusor instabil i ty, is that many publications dealing wi th 
new treatments must be taken with a grain of salt. 
Unt i l significantly improved forms of therapy (together wi th their 
long-term results) are known, it seems advisable to remain conservative 
in the treatment of detrusor instabil i ty. 
Part II. Emptying disorders of the bladder. 
Chapter V I . 
Further experiences wi th intravesical prostaglandin as a method of treat-
ment for urinary retention owing to impaired detrusor funct ion have 
again conf irmed itsci inical value (Desmond et al., 1980; Vaidyanathanei 
al., 1981). However, despite incontestable evidence of an effect on the 
bladder funct ion as shown both in vi tro and in vivo, we feel somewhat 
embarrassed because of the lack of response in our own patients. Never-
theless, Stanton et al. (1979), in assessing the value of prostaglandin on 
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urodynamically normal bladders to relieve delayed onset of voiding after 
colposuspension operations, also found no therapeutic effect. We may 
indeed wonder what k ind of functional bladder abnormal i ty shows a res-
ponse to intravesically applied prostaglandin. 
The precise mechanism of the facil i tating influence of prostaglan-
din on the mic tur i t ion contraction is not clearly known. In general, it is 
thought that the mode of action of prostaglandin consists of a modula-
ting effect upon the ganglionic transmission; by excit ing the parasym-
pathetic ganglia, acetylcholine is released (Taira et al., 1975; Choo and 
Mitchelson, 1977; Kushiku and Furukawa, 1980). Kondo et al., have 
found that the chronically denervated bladder is supersensitive to intra-
venous prostaglandin and this effect is similar to that seen wi th bethane-
chol chloride (1980). This phenomenon appears to be in accordance wi th 
the law of denervation which states that a denervated organ demonstrates 
an increased sensitivity to neurotransmitters (Cannon, 1939). Therefore, 
it may be plausible to assume that a favourable response to prostaglandin 
can only be expected in bladders which have been deprived of their in-
nervation. Furthermore, it has been shown that prostaglandin-induced 
reflex voiding can be achieved in selected patients w i th preganglionic 
denervation of the bladder (Vaidyanathan et al., 1981). The fact that 
the patients we studied did not fu l f i l these criteria may be the reason 
for the negative results. 
Chapter V I I . 
It is certain that the att i tude towards a cystocele or anterior vaginal wall 
prolapse, often wi th concomitant uterine prolapse, wil l be different f rom 
the point of view of the gynaecologist compared wi th that of the urolo-
gist. When discussing a surgical plan for treatment of a large cystocele, 
one should take account of the gynaecological as much as the urologica! 
problems. The gynaecological factors especially consist of a vaginal vault 
prolapse and/or a uterine prolapse. The possible urinary problems wi l l be 
dependent on the degree of anterior vaginal wall descent. There are three 
major urological symptom-complexes which are frequently related to 
uterovaginal prolapse. Cases with mild to moderate cystocele are often 
associated wi th urinary stress incontinence, whereas in more severe de-
grees, obstructive urinary symptoms wi th inadequate bladder emptying 
wil l be in the foreground. Indeed, it must be emphasised that a large 
cystocele frequently protects the patient f rom urinary incontinence. It 
is our belief that the obstructive symptoms are often underestimated and 
the causal relationship between these symptoms and the presence of a 
massive cystocele is sometimes misjudged. A th i rd urological complica-
t ion that may be encountered (and needs to be recognised in cases of 
massive cystocele or uterine prolapse) is hydro-ureteronephrosis as a re-
sult of ureteric obstruct ion (Delaere, 1982; Delaere et al., in press). 
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There has been much written and infinitely discussed about the 
surgical approach to the perplexing problem of large cystocele. Some 
people are in favour of colpopexy by the vaginal route (Richter and 
Albrich, 1981), while others prefer an abdominal approach (Macer, 
1978). Still others use a combined operation. It is our opinion that only 
with the greatest difficulty can a large cystocele be adequately corrected 
solely by a vaginal repair. Adequate elevation of the bladder neck is not 
easy to achieve vaginally, resulting in permanent or induced urinary in-
continence. (Stanton et al., 1982; Peters et al., 1981). However, with 
regard to the proper gynaecological problem, we can to a certain extent 
accept that it may be possible to remove the excess vaginal mucosa of 
the (moderate) cystocele by means of an anterior colporrhaphy. But 
generally, the problem of urinary incontinence, due to urethral sphinc-
ter inompetence will not be solved and the possibility arises of posto-
perative lower urinary tract disorders, which are often seen when repair 
operations are carried out from below (Chapter XII I) . The problem 
of incontinence usually requires a suprapubic approach. Moreover, it has 
been shown that vaginal repair reduces urethral resistance, as opposed to 
suprapubic colposuspension which tends to increase outflow obstruction 
(Walter et al., 1981). 
In short, there are three reasons why we prefer an abdominal ap-
proach to correct a massive cystocele: 
1. One of the surgical steps in the reposition of a huge cystocele should 
consist of a suprapubic colposuspension to relieve the symptoms 
caused by sphincter incompetence and/or to prevent stress inconti-
nence postoperatively. 
2. It is often impossible to reduce an extensive descent of the bladder by 
the vaginal route alone. 
3. It is our experience that, if an anterior colporrhaphy is complicated 
by micturition disturbances, the urologist is often faced with an in-
soluble problem. 
The patients we treated have presented primarily with obstructive 
micturition disorders ascribed to the presence of a massive cystocele. 
Our strategy in these patients is based upon a reduction or disappearance 
of the anterior vaginal wall prolapse by means of fixation of the vaginal 
vault or uterus to the sacral promontory. To correct a concomitant stress 
incontinence or to prevent postoperative incontinence, an additional col-
posuspension according to Burch is required. This repositional procedure 
yields satisfactory results in our hands. In common slight cases of utero-
vaginal prolapse without obstructed micturition, we can assume that the 
gynaecological problems can be solved by abdominal or vaginal removal 
of the uterus, if still present, with fixation of the vaginal vault to the 
shortened uterosacral ligaments and some Burch's stitches if desired. 
It is concluded that in an individual case of large cystocele, a 
thorough analysis of both the urological and gynaecological symptoms 
should lead toa well-considered surgical plan. From the urological point 
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of view, suprapubic reposition seems desirable to treat the urinary pro-
blems and at the same time, to guard against additional urinary problems. 
Chapter VIM. 
It hardly needs saying that transurethral bladder neck incision is an effec-
tive method for treating bladder neck contracture. Also in cases of small 
prostatic enlargement this procedure seems very useful, on the under-
standing that the incision is extended to the verumontanum. It is true 
that the efficiency of the endoscopic prostatotomy in case of moderate 
hypertrophy of the prostate may be questionable. Nevertheless, we pre-
fer this technique for such indications when we are dealing with elderly 
high risk patients. However, it is our experience that there is often a 
delayed onset of voiding postoperatively. This may be due to oedema of 
the incised adenoma. Mostly, after some days or weeks, an unobstructed 
micturition is instituted. And it is our policy, when relief of the obstruc-
tive symptoms is not achieved immediately, to wait for at least two 
months before to decide to re-intervene. 
In the comment of Wein (1984) on our article, he states that, 
when the prostate lobes are incised, the released portions tend to prolapse 
into the lumen, giving the impression that there is more (rather than less) 
obstruction. In such a case, he proceeds with transurethral resection. 
Our experiences are similar with regard to the endoscopic appearance of 
permanent obstruction after extended incision but we suppose that it is 
an optical illusion. 
Another additional remark concerns the occurrence of retrograde 
ejaculation. With the intention of lowering the incidence of this condi-
tion, it appears not to be important whether one makes one or more in-
cisions. On the other hand, it is logical that the further the incision con-
tinues to extend inferiorly, the greater the chance of retrograde ejacula-
tion. Thus, not the number but the length of the incisions is what deter-
mines whether retrospermia will occur postoperatively. 
Chapter IX. 
We are convinced that the transurethral incision of the female bladder 
neck constitutes a perilous enterprise. Therefore, the aim of our contri-
bution about this procedure in the female is a warning one, particularly 
for fear of postoperative incontinence and because the anticipated result 
is obtained in only 56% of our patients. These moderate results are 
mainly related to the acontractile state of the detrusor. In all our cases, 
the indication for endoscopic incision was to improve bladder emptying. 
We do not advocate bladder neck resection because an incision is 
more simpleand yet less time-consuming. Furthermore, there is no ques-
tion that Y-V-plasty of the bladder neck belongs to the history of bladder 
neck surgery. It has been claimed that transurethral incision reduces the 
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incidence of incontinence, in comparison wi th bladder neck resection 
(Pinard, 1969; Keitzer and Al len, 1970). However, we doubt this asser-
t ion. It is our opinion that postoperative incontinence depends on the 
critical length and depth of either the incision or the resection of the 
bladder neck. 
These critical factors in their t u rn , are determined mainly by the 
closure pressure of the bladder neck and next by the funct ion of the 
detrusor and the pelvic f loor. In this train of thought, it may be evident 
that a (too) l imited incision or resection of the bladder neck in case of 
detrusor failure wi th a normal closure pressure of the proximal urethra 
wil l usually yield no improved bladder evacuation. On the contrary, a 
(too) extensive incision in case of a normal contracti le bladder wi th a 
diminished urethral closure pressure, holds the possibility of postopera-
tive incontinence. 
Al though our series is small, we found a persistent incontinence 
rate of 6,2%. Ray reported an incontinence rate of 2% after transurethral 
incision (1967). Morb id i ty f rom incontinence in our patients was consi-
derable, and they could not be managed successfully either by conserva-
tive or surgical methods. 
It must be emphasised again that the procedure discussed, for fe-
males wi th emptying disorders, can only be performed in selected well 
considered cases, which have been subjected to ful l urodynamic investi-
gation, and then only when alternative possibilities such as intermit tent 
catheterisation or alpha-adrenergic blocking medication have been pro-
ved to be inadequate or not appropriate. 
Part III. The influence of some pharmacolo-
gic agents on the lower urinary tract. 
Chapters X and X I . 
Drug-induced urinary incontinence has become more frequently reported 
in the past decade. Urinary incontinence as a side effect of commonly 
used drugs is mostly due to interaction wi th the alpha-adrenergic recep-
tors located predominantly in the bladder base and proximal urethra. 
The prostatic capsule also seems to be extremely rich in alpha-adrenergic 
receptors (Caineefa/ . , 1975). 
St imulat ion of these receptors by the neurotransmitter norepine-
phrine, released by postganglionic sympathetic fibres, causes a contrac-
t ion of the bladder neckand proximal urethra. In urological practice, th< 
alpha-adrenergic blocker phenoxybenzamine (Dibenyl ineR ) is commonly 
used wi th success to improve voiding in patients wi th neurogenic bladder 
obstruct ion and obstructive prostatic symptoms (Stockamp and Schrei-
ter, 1975 ;Borehamefa / . , 1977;Harr isonefa/ . , 1977; Awad et al., 1978; 
Hachen, 1980). 
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There are two mam groups of drugs which may produce unwanted 
urinary incontinence· neuroleptics and antihypertensive agents. Pheno-
thiazmes (chloropromazme, thioridazine) and butyrophenones (halopen-
dol) have been cited in several reports as causing urinary incontinence 
(Van Putten et al , 1973, Ambrosim and Nürnberg, 1980;Shenoy, 1980). 
Induction of incontinence by these drugs is probably due to a centrally-
mediated effect (Kiruluta and Andrews, 1983). 
Alpha-methyldopa (A ldomet R ) , guanethidme ( lsmelmeR ) and 
prazosin (MinipressR) are antihypertensive drugs of which it is known 
that they may produce urinary incontinence. In recent years, this side 
effect (as a result of lowered urethral resistance) has been used to treat 
patients wi th neurogenic out f low obstruction and prostatic obstruct ion 
(Razef al., 1977, Fmkbemer et al , 1979, Anderssonef al., 1981 , Jensen, 
1981, Hedlund et al , 1983). 
In the same year as our publ icat ion of the first case of stress in-
continence due to prazosin, a second case was reported by Straughan 
(1978). Since then, another case has been published (Kiruluta et al., 
1981). The hypotensive effect of prazosin is thought to be a consequence 
of blockade of alpha-adrenoceptors, causing peripheral vasodilatation. 
Urinary incontinence occurs by blocking these receptors m the proximal 
urethra, particularly m susceptible women wi th a borderline urethral 
pressure Prazosin seems to have fewer side effects than phenoxybenza-
mine and isthereforea welcome alternative drug for condit ions m which 
relaxation of the bladder neckand urethra is desired. Moreover, prazosin 
has also proved to be valuable in the treatment of patients wi th neuro-
genic uninhibited bladders (Jensen, 1981). This therapeutic effect on 
increased bladder activi ty is thought to be due to the blockade of alpha-
adrenergic receptors located wi th in the bladder wall . 
Alpha-methyldopa, another antihypertensive drug which can in-
duce urinary incontinence, has sympathicolyt ic properties and probably 
acts wi th in the central nervous system (Raz, 1974, Fernandez et al., 
1981). Its relaxing effect on the urethra has been utilised to improve 
bladder emptying m patients wi th neurogenic bladder diseases (Raz et 
al , 1977). 
The action of guanethidme is mediated by suppression of both 
alpha- and beta-adrenergic receptors (Nickerson and Collier, 1975). 
Urinary incontinence is a frequent side effect of guanethidme administra-
t ion The use of this drug m the treatment of urinary retention m pa-
tients wi th spinal cord injury is probably based upon decreased beta-
adrenergic activity of the bladder, together wi th diminished alpha-
adrenergic influence of the bladder neck (Fmkbemer et al., 1979). On 
the other hand, transient urinary retention may be encountered at the 
beginning of treatment for hypertension, since guanethidme may ini t ial ly 
cause sympathomimetic effects due to release of norepinephrine f rom 
the storage granules (Bateson et al , 1973, Nickerson and Collier, 1975). 
It is concluded that several antihypertensive drugs may produce 
incontinence due to sphincter insufficiency, particularly in susceptible 
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women with sub-normal urethral pressures. This property has been 
readily utilised in the treatment of outflow obstruction. 
Chapter XI I . 
It is not yet possible to assess if ketanserin as a serotonin antagonist 
(with proved relaxant effect on the urethra when administered intrave-
nously) will be available as an oral drug for conditions where relaxation 
of the bladder neck and urethra is wanted. We are starting a prospective 
trial in patients with prostatic obstruction to evaluate its value in relie-
ving obstructive symptoms. Ketanserin will be proposed in the near fu-
ture for the management of moderate forms of hypertension. As it has 
only few side effects, less than the commonly used sympathicolytic 
agents, it is hoped that this new drug may be as active as phenoxybenza-
mine on the lower urinary tract. 
Part IV. Iatrogenic disturbances of the lower 
urinary tract. 
Chapter XI I I . 
It is not our intention to go further into the matter of indications for 
anterior colporrhaphy. This is essentially a typical gynaecological pro-
blem. Nevertheless, urologists are often concerned in the discussion with 
gynaecologists whether the correction of genuine stress incontinence 
needs to be done by a suprapubic approach or by an anterior vaginal re-
pair. Indeed, there is some controversy about the place of vaginal surgery 
in the management of stress incontinence. It is now, however, widely 
accepted that the cure rates achieved by a suprapubic colposuspension 
are higher than those for vaginal surgery (Jeffcoate, 1967; Hodgkinson, 
1970; Morgan, 1973; Stanton and Cardozo, 1979). The criteria accor-
ding to Green (1962), for selecting the type of operation (vaginal or 
suprapubic, depending on the size of the vesico-urethral angle) seem to 
be obsolete. Fore more than a decade, no attention has been paid in the 
urological literature to the posterior urethrovesical angle, and it is no 
longer thought that this angle has any diagnostic significance. One should 
consider urinary incontinence as a urodynamic dysfunction, whereas 
geometrical findings must be regarded only as of secondary importance. 
A second reason why urologists, to a certain extent, are involved 
in anterior vaginal repairs is related to the possible urological complica-
tions. In our contribution we have asserted that anterior colporrhaphy 
is responsible for a variety of micturition disorders. However, one of the 
greatest disadvantages of our study is that it concerns a retrospective ana-
lysis with the well known limitations inherent in such an investigation. No 
preoperative urodynamic examinations were available, because the pa-
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tients were only admitted to our urological department after a previous 
vaginal prolapse operation had already been performed. The intention of 
our analysis was to emphasise the urinary problems which may develop 
after vaginal surgery, and to suggest a reconsideration of the indications 
for this procedure. We do not pretend at all, however, that anterior vagi-
nal repair is a valueless operation, because we have not been able to docu-
ment the percentage of patients who had a satisfactory outcome follo-
wing anterior colporrhaphy. Indeed, it is accepted that the ability of an-
terior vaginal repair to correct vaginal wall prolapse is unquestioned 
(Stanton et al., 1982). Moreover, we have to confess that suprapublic 
techniques for curing stress incontinence also have their complications. 
Postoperative detrusor instability has been noted after colposuspension 
in 18.5% of cases (Cardozo et al., 1979). These authors hypothesise 
that postoperative instability could be due to excessive urethral com-
pression with outflow obstruction and consequent detrusor instability, 
or to damage to the nerve supply to the bladder. Adequate reports with 
preoperative and postoperative urodynamic examinations in patients 
undergoing anterior vaginal repair are hardly available at all. In a well 
documented study by Stanton et al., (1982), detrusor instability follo-
wing anterior colporrhaphy was even not noticed, and voiding difficul-
ties were also not encountered. However, vaginal repair seemed unsuc-
cessful in correcting sphincter insufficiency. These findings and conclu-
sions are in contrast with our own results. 
The ultimate result of an anterior colporrhaphy will depend on a 
number of factors, such as the correct indication, the experience and the 
operative skill of the gynaecologist. It was striking that the majority of 
the patients with urological complaints, as evaluated in our retrospective 
study, had nearly always been operated upon vaginally by the same 
small number of gynaecologists. We rarely (if ever) have seen patients 
from the other gynaecologists in our region because of postoperative 
urological problems. This may explain again that the operative techni-
ques used, together with the surgeon's skill, are the most important fac-
tors in preventing postoperative micturition disorders. In fact, it is no 
wonder that reports published by experienced and conscienttous gynae-
cologists on their own patient material only seldom disclose a complica-
ted case. 
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Samenvatting 
In de afgelopen jaren werd op de Afdeling Urologie van het Sint Radboud-
ziekenhuis te Nijmegen zowel prospectief als retrospectief onderzoek 
verricht bij patiënten met functionele en anatomische afwijkingen van de 
lagere urinewegen. De resultaten van de meeste van deze studies werden 
reeds gepubliceerd. Dit proefschrift is een samenbundeling van deze pu-
blicaties, en bestaat uit vier delen: (1) therapeutische aspecten van mo-
torische urge incontinentie; (2) ontledigingsstoornissen van de blaas met 
aandacht voor enkele behandelingsmodaliteiten; (3) invloed van bepaalde 
farmaca op de lagere urinewegen, in het bijzonder van urethratonus-ver-
lagende middelen; (4) iatrogene afwijkingen van de lagere urinewegen. 
Elk deel is samengesteld uit één of meerdere hoofdstukken. Het proef-
schrift eindigt met algemene beschouwingen en conclusies, waarbij 
nieuwere inzichten worden besproken en de meest recente literatuurge-
gevens ter discussie worden gesteld. 
DEELI . 
In het eerste deel worden de volgende proolemen aan de orde gesteld: 
(1) Wat is de waarde van geneesmiddelen in de behandeling van moto-
rische urge incontinentie? (2) Is de langdurige hydrostatische blaasdis-
tentie nog gerechtvaardigd bij patiënten met urge incontinentie of detru-
sorhyperreflexie bij wie eerdere medicamenteuze therapie faalde of ge-
staakt moest worden wegens ongewenste bijwerkingen? 
In hoofdstuk I worden de resultaten besproken van 42 patiënten 
die behandeld waren met flavoxaat hydrochloride (UrispasR ). De patiën-
ten hadden klachten als urge, Pollakisurie, nycturie, urge incontinentie 
en enuresis nocturna. Bij allen werd door middel van urodynamisch on-
derzoek een instabiele detrusor aangetoond. Het betreft hier een gese-
lecteerde groep patiënten waarbij eerdere behandeling met propantheline 
bromide (ProbanthineR ) en/of emepronium bromide (CetiprinR) niet 
tot het gewenste resultaat leidde. 
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Flavoxaat hydrochloride is een gladde-spier-relaxans met farmaco-
logische eigenschappen die vergelijkbaar zijn met die van papaverine. Bij 
de meeste patiënten kon geen duidelijke oorzaak ter verklaring van hun 
detrusorinstabiliteit vastgesteld worden (primaire of idiopathische insta-
biele blaas). Enkelen hadden een neurologisch basislijden. De toegedien-
de dosis flavoxaat hydrochloride bedroeg 600 tot 800 mg per dag. Eva-
luatie der symptomen vond plaats 2 tot 18 maanden na het begin der 
behandeling. Bij enkele patiënten werden bijwerkingen genoteerd als al-
gehele malaise, braken, hoofdpijn en misselijkheid. Tijdens de behande-
ling werden 5 patiënten (12%) volkomen klachtenvrij, terwijl door 11 
patiënten (26%) een lichte symptomatische verbetering werd gemeld. De 
overige patiënten ondervonden geen enkele baat bij de behandeling. In 
de literatuur worden over het algemeen (veel) betere resultaten beschre-
ven. Wellicht heeft dit te maken met het feit dat in die gevallen flavoxaat 
als eerste behandeling werd voorgeschreven. 
In hoofdstuk II wordt nagegaan in hoeverre bromocriptine 
(Parlodel") therapeutisch bruikbaar is bij patiënten meteen instabiele 
detrusor. Bromocriptine (2-bromo-alfa-ergocryptine) is een prolactine 
antagonist en een dopamine agonist. Het exacte werkingsmechanisme 
op de blaasspier is niet geheel duidelijk. Wel blijkt bromocriptine een 
zekere antagonistische werking te hebben ten opzichte van de parasym-
pathische neurotransmitter acetylcholine. Achttien patiënten met urge 
incontinentie, niet reagerend op eerdere medicamenteuze behandeling 
en/of blaasdistentie, werden in de studie opgenomen. De behandeling 
duurde 6 weken. De orale dosis bedroeg 2,5 mg tweemaal daags. Tien 
patiënten hadden bijwerkingen waaronder misselijkheid, braken, luste-
loosheid, duizeligheid, obstipatie en hoofdpijn. Slechts 2 patiënten gaven 
enige verbetering van hun urologische klachten aan. Onze conclusie was 
dan ook dat bromocriptine ongeschikt is als therapeuticum bij detrusor-
hyperreflexie, ondanks het feit dat andere auteurs wel veelbelovende re-
sultaten hebben vermeld. 
De resultaten van een prospectief onderzoek met indomethacine 
(lndocidR) bij patiënten met een instabiele blaas zijn weergegeven in 
hoofdstuk I I I . Daar de blaastonus en -contractiliteit niet alleen afhanke-
lijk blijken te zijn van de parasympathische neurotransmitter acetylcho-
line, maar eveneens van Prostaglandines, is het aannemelijk te pogen de 
blaasactiviteit te reduceren met een Prostaglandine synthetase remmer, 
zoals indomethacine. Vijfenvijftig patiënten met een primaire therapie-
resistente detrusorhyperreflexie namen deel aan het onderzoek. De be-
handeling duurde 6 weken en de dosis indomethacine bedroeg 50 mg 
tweemaal daags. Bijwerkingen van de medicatie (zuurbranden, hoofdpijn, 
duizeligheid en misselijkheid) werden veel gezien (42% der patiënten). 
Slechts 8 patiënten (17%) meldden dat hun symptomen geheel of ge-
deeltelijk verdwenen tijdens de behandeling. Mede gezien het hoge per-
centage bijwerkingen achtten wij dit geneesmiddel niet geschikt voor de 
behandeling van detrusorinstabiliteit. 
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In hoofdstuk IV en V worden onze ervaringen gerapporteerd met 
de langdurige hydrostatische blaasdistentie bij refractaire gevallen van 
detrusorhyperreflexie. Onder controle van bloeddruk en blaasdruk 
wordt, gedurende viermaal 30 minuten, de blaas gedistendeerd tot een 
intravesicale druk is bereikt welke gelijk is aan of iets lager is dan de sys-
tolische bloeddruk. De blaasdistentie geschiedt onder epidurale of alge-
hele anaesthesie. Het werkingsmechanisme van het behandelingseffect is 
nog niet geheel duidelijk. Op theoretische gronden mag aangenomen 
worden dat tijdens blaasdistentie ischemische en mechanische letsels ont-
staan in de blaaswand door dichtdrukken van de capillaire bloedvaten en 
door de verkregen hoge wandspanning. Hierdoor is een zekere destructie 
te verwachten van de meest gevoelige structuren, zoals de zenuwuitein-
den en de neuro-musculaire juncties, en een overrekking van de spierve-
zels. Onze eerste resultaten bij 22 patiënten waren redelijk te noemen, 
zeker wat betreft de resultaten op korte termijn (hoofdstuk IV). Bij con-
trole door middel van urodynamisch onderzoek, ongeveer 3 maanden na 
de distentie, kon een stabiele detrusorfunctie worden geregistreerd bij б 
patiënten (27%); 7 patiënten (32%) waren cotinent geworden, terwijl 
een verbetering der symptomen werd genoteerd bij 6 patiënten (27%). 
Als belangrijkste complicaties werden gezien: tweemaal een blaasruptuur 
en tweemaal een tijdelijke acontractiliteit van de blaas. 
In hoofdstuk V worden in totaal 77 blaasdistenties geanalyseerd, 
uitgevoerd bij 67 patiënten. Speciale aandacht wordt geschonken aan de 
resultaten op langere termijn en aan de resultaten van een tweede disten-
tie. Een postoperatievecystometrie werd uitgevoerd bij 36 patiënten. Bij 
7 van hen (19%) werd nu een stabiele blaas gezien. Duidelijk werd dat 
het percentage gunstige resultaten afhankelijk is van het tijdstip waarop 
de analyse der symptomen plaatsvindt. Subjectieve beoordeling van de 
symptomen na 3 maanden toont een volledige genezing bij 13 patiënten 
(17%) en een verbetering in 22 gevallen (29%). Evaluatie na 1 jaar echter 
levert nog slechts een totale genezing op bij 11% der behandelde patiën-
ten en een relatieve verbetering bij 21%. De resultaten na een tweede 
distentie zijn minder goed dan na een eerste distentie. In totaal werden 
8% der distenties gecompliceerd door een blaasruptuur. De gemiddelde 
blaasdruk op het moment van de ruptuur was echter niet hoger dan in de 
ongecompliceerde distenties. Al deze rupturen werden operatief gesloten. 
In 2 gevallen trad tijdelijk geen spontane mictie op, terwijl het cystome-
trogram bij een andere patiente na 6 maanden nog steeds een acontrac-
tiele detrusor aantoonde. Bij 24% der behandelde patiënten werd tijdens 
de blaasdistentie de intravesicale druk opgevoerd tot gemiddeld 15 mm 
Hg boven de systolische bloeddruk. Dit leidde echter niet tot betere post-
operatieve resultaten. Wegens de hoge recidieffrequentie vooral tijdens de 
eerste 3 maanden, en mede gezien de te verwachten complicaties, werd 
besloten deze procedure te schrappen uit ons therapeutisch arsenaal. 
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DEEL I I . 
In deel II worden enkele minder gangbare therapeutische mogelijkheden 
besproken voor de behandeling van diverse soorten ontledigingsstoornis-
sen van de blaas. Gepoogd werd op de volgende vragen een antwoord te 
geven: (1) Zijn intravesicale blaasinstillaties met Prostaglandines in staat 
om de blaascontractiliteit te herstellen? (2) Wat zijn de resultaten van 
een fixatie van de vaginatop aan het Promontorium (colpopromontorio-
pexie) bij patiënten waarbij een uitgesproken cystocele oorzaak is van 
dysurie en vaak onvolledige mictie? (3) Wat zijn de indicaties voor, en de 
resultaten van de endoscopische blaashalsincisie ter behandeling van de 
geobstrueerde mictie, zowel bij mannen als bij vrouwen? 
In hoofdstuk VI wordt melding gemaakt van de resultaten van 
intravesicale blaasinstilaties met Prostaglandine E2 (PGE2) en F2a 
(PGFïtt) bij 13 vrouwen met ontledigingsstoornissen van de blaas. Dier-
experimenteel onderzoek heeft aangetoond dat PGE2 en PGF2a stimu-
lerende eigenschappen hebben op de blaasmusculatuur. Ook in humane 
studies, zowel in vitro als in vivo, zijn dezelfde contractiele effecten aan-
getoond. De invloed van Prostaglandines op de urethra is nog niet geheel 
duidelijk. Bij de meeste patiënten toonde het urodynamisch onderzoek 
geen blaascontractie op commando. Een intravesicale obstructie als oor-
zaak van het chronisch blaasresidu kon in a Ne gevallen worden uitgesloten. 
De blaasinstillatie duurde meestal 30 minuten; in enkele gevallen werd de 
blaas gedurende 60 minuten gei'nstilleerd met 50 ml van een prostaglandi-
neoplossing. De prostaglandine-dosis varieerde van 0,5 mg tot 10 mg 
PGE2 en van 1 mg tot 5 mg PGFjO. Onmiddellijk na de mstillatie werd 
het urodynamisch onderzoek herhaald. Al met al konden geen significan-
te veranderingen van de urodynamische parameters worden vastgesteld. 
Wel werd bij 3 patiënten enige afname van het blaasresidu genoteerd. Bij 
6 patiënten werden oppervlakkige blaasbiopten genomen, onmiddellijk 
voor en direct na de mstillatie, om na te gaan in hoeverre Prostaglandine 
wordt geabsorbeerd door de blaasmucosa. Uit prostaglandine-bepalingen 
in deze biopten konden echter geen duidelijke conclusies worden getrok-
ken. De therapeutische bruikbaarheid van prostaglandine-blaasinstilla-
ties hebben wij dus niet kunnen aantonen. 
De aanwezigheid van een cystocele kan oorzaak zijn van tal van 
mictiestoornissen. In hoofdstuk VII wordt hierop nader ingegaan. Een 
beperkte descensus van de vaginavoorwand wordt vaak aangetroffen bij 
patiënten met stress incontinentie, terwijl daarentegen een uitgesproken 
cystocele aanleiding kan geven tot een bemoeilijkte mictie en chronisch 
residu. Wij bestudeerden 22 vrouwen van wie werd aangenomen dat een 
forse cystocele verantwoordelijk was voor de moeizame en vaak onvol-
ledige mictie. Opvallend hierbij was dat vele vrouwen hun blaas alleen in 
voorovergebogen houding konden ledigen. Tal van patiënten ondergingen 
reeds eerder een medicamenteuze behandeling en/of een desobstruerende 
ingreep ter behandeling van hun obstructief mictiepatroon. Deze behan-
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delingen hadden echter met het gewenste resultaat, waarschijnlijk omdat 
de bestaande cystocele met als de oorzaak van de dysurie werd gezien. 
Enkele patiënten hadden daarenboven een lichte vorm van stress incon-
tinentie Een repositie van de cystocele werd verkregen door fixatie langs 
transperitoneale weg van devagmatopof de cervix uteri aan het Promon-
torium. Omdat stress incontinentie kan optreden na een geslaagde correc-
tie van een voorwandprolaps, werd de colpopromontonopexie meestal 
gecompleteerd met een colposuspensie volgens Burch. Postoperatief 
konden 16 van de 22 geopereerde patiënten weer vlot en zonder residu 
plassen BIJ 3 patiënten werd het resultaat als slechts matig beoordeeld, 
terwijl nog eens 3 patiënten geen enkele verbetering toonden Deze 
laatste 3 patiënten hadden al eerder een prolaps-operatie ondergaan, 
postoperatieve urethrale fibrose was mogelijk toch oorzaak van een blij-
vende obstructieve mictie Een van de voordelen van deze transabdomi-
nale benadering boven een correctie langs vaginale weg is dat het sf mcter-
mechamsme en het trigonale gebied intact worden gelaten. 
De indicaties en de resultaten van de endoscopische blaashalsmcisie 
volgens Turner-Warwick, bij 32 mannen met een outflow obstructie, 
worden besproken m hoofdstuk VI I I . Er wordt ingegaan op de differen-
tiële diagnostiek tussen anatomische en functionele infravesicale obstruc-
tie De waarde van het urodynamisch onderzoek wordt hierbij aan een 
kritische beoordeling onderworpen. Negentien patiënten (59%) hadden 
een secundaire blaashalssclerose ontwikkeld na een prostatectomie of een 
TUR prostaat De overige indicaties voor transurethrale blaashalsmcisie 
waren kleine obstructieve prostaat, functionele blaashalsdyssynergie en 
acontractihteit van de blaas. Met een verticale naaldelectrode wordt de 
blaashals diathermisch op 4 en 8 uur geïndiceerd tot aan het peri-
urethrale vetweefsel. De incisies breiden zich naar distaal uit tot aan het 
verumontanum (Prostatotomie). Subjectieve verbetering trad op bij 26 
van de 32 patiënten (81%) BIJ objectieve postoperatieve evaluatie door 
middel van flowmetrie en van residubepaling werd m hetzelfde aantal 
gevallen succes geconstateerd. BIJ jongere mannen met een functionele 
blaashalsobstructie is een endoscopische blaashalsmcisie zeker te verkie-
zen boven een TUR, om het risico van postoperatieve retrograde ejacu-
latie zo laag mogelijk te houden BIJ de oudere high risk patient met 
prostatismeklachten heeft de blaashalsmcisie het grote voordeel slechts 
enkele minuten te duren en weinig traumatisch te zijn. 
In hoofdstuk IX wordt aandacht besteed aan de endoscopische 
blaashalsmcisie bij vrouwelijke patiënten. Terwijl bij mannen de oorzaak 
van outflow obstructie meestal gelegen is m een te hoge infravesicale 
weerstand, is de oorzaak van dysurie en chronische retentie bij de vrouw 
meestal het gevolg van een atone of onvoldoende contractiele blaas. Van 
de 32 behandelde patiënten werd tijdens urodynamisch onderzoek een 
acontractiele detrusor gevonden bij 20 patiënten (63%) BIJ de overige 
patiënten werd de diagnose mechanische (iatrogene) blaashalsobstructie 
gesteld Een diathermische blaashalsmcisie werd verricht op 12 uur (in 
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lithotomiehouding). De lengte van de incisie was beperkt tot hooguit het 
proximale derde deel van de urethra. Slechts bij 18 patiënten (56%) werd 
een redelijk tot goed resultaat bereikt. Bij б patiënten was een herhalings-
incisie noodzakelijk en bij 2 van hen resulteerde dit in stress incontinentie. 
Patienten met een mechanische blaashalsobstructie hadden over het alge-
meen betere resultaten dan patiënten met een detrusorzwakte. Het is 
moeilijk (en soms gevaarlijk) om in geval van een insufficiënte detrusor 
het evenwicht tussen blaas- en sfincterfunctie te herstellen door middel 
van een blaashalsincisie. Het is in feite preoperatief onmogelijk om pre-
cies te bepalen hoe uitgebreid de incisie moet zijn. Een te uitgebreide in-
cisie kan sfincterinsufficiëntie als gevolg hebben, terwijl een te beperkte 
incisie de balans tussen blaas en urethra niet steeds zal corrigeren. Dit is 
dan ook de reden waarom de resultaten bij vrouwelijke patiënten bedui-
dend minder goed zijn dan bij mannen. Mede wegens het potentiële ge-
vaar van iatrogene incontinentie moet men in geselecteerde gevallen inter-
mittente (zelf-)catheterisatie als waardevol alternatief voor ogen houden. 
DEEL I I I . 
De relatie tussen het gebruik van sommige antihypertensiva en het voor-
komen van incontinentia urinae wordt bestudeerd in deel I I I . Voorts 
wordt onderzocht op welke wijze een serotonine antagonist de functie 
van blaas en urethra beïnvloedt. 
In hoofdstuk X wordt het eerste geval beschreven van stress incon-
tinentie als gevolg van het gebruik van het antihypertensivum prazosine 
(MinipressR). De antihypertensieve werking van prazosine zou groten-
deels berusten op alfa-sympathicolytische activiteit, hetgeen een relaxatie 
van de blaashals kan veroorzaken met stress incontinentie als gevolg. De 
blaashals bevat namelijk veel alfa-adrenerge receptoren. In de beschreven 
casus werd een zeer duidelijke daling van de urethradruk geregistreerd 
tijdens de behandeling met 12 mg prazosine per dag. 
De invloed van enkele andere antihypertensiva met alfa-sympathi-
colytische werking op de urethrale sfinctertonus en continentie wordt 
besproken in hoofdstuk XI . Vrouwelijke patiënten met hypertensie 
werden behandeld met respectievelijk prazosine (MinipressR), guanethi-
dine (lsmelmeR) en alfa-methyldopa (AldometR). Onder behandeling 
werd meestal een lagere urethrale druk gemeten. Bij enkele patiënten re-
sulteerde dit in incontinentie of toename van een reeds bestaande stress 
incontinentie. Geconcludeerd wordt dat bij elke patient met incontinen-
tia urinae het aangewezen is de bloeddruk te meten. Is er sprake van 
sfincterzwakte bij aanwezige hypertensie, dan is er een contraindicatie 
voor de medicamenteuze behandeling van de incontinentie door middel 
van sympathicomimetica zoals efedrine hydrochloride. Verder dient bij 
elke patient met stress incontinentie navraag te worden gedaan naar even-
tueel gebruik van antihypertensieve medicatie. Bestaat deze uit prazosine, 
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guanethidine of alfa-methyldopa, dan verdient het aanbeveling deze me-
dicatie te stoppen en na te gaan in hoeverre de incontinentie verdwijnt, 
vooraleer over te gaan to t operatieve correctie van de incontinentie. 
Op zoek naar nieuwe geneesmiddelen welke een relaxerend effect 
hebben op de blaasspier werd een prospectief onderzoek gestart met ke-
tanserin, een serotonine antagonist. In hoofdstuk XI I worden de urody-
namische veranderingen weergegeven bij 17 patiënten aan wie 10 mg ke-
tanserin intraveneus werd toegediend. Het is bekend dat de neurotrans-
mitter serotonine of 5-hydroxytryptamine in staat is de blaasactiviteit te 
doen toenemen. Verwacht werd dan ook dat een serotonine antagonist 
klinisch bruikbaar zou kunnen zijn bij de behandeling van detrusorhyper-
reflexie. Er werden evenwel 20 minuten na intraveneuze toediening van 
ketanserin geen wezenlijke veranderingen van functionele blaascapaciteit 
en mict iedruk geregistreerd. Ook bij enkele patiënten met een instabiele 
detrusor was het niet mogelijk een stabiele blaasfunctie te verkrijgen. 
Wel kon een verhoogde uitstroomsnelheid ( f low rate) worden aangetoond 
bij vrouwen met een stabiele detrusor, hetgeen een verminderde infrave-
sicale weerstand doet vermoeden. Inderdaad toont het urethradrukpro-
fiel een significante daling van de maximale urethradruk, welke daling 
het sterkst is 15 minuten na intraveneuze toediening van ketanserin. Dit 
gegeven suggereert een alfa-sympathicolytische werking van ketanserin. 
Geconcludeerd wordt dat ketanserin mogelijk bruikbaar kan zijn bij de 
behandeling van ou t f low obstructie, indien een relaxatie van blaashals 
en (proximale) urethra wordt beoogd. 
DEEL IV. 
Iatrogene pathologie van de lagere urinewegen na een vaginale voorwand-
plastiek wordt besproken in hoofdstuk X I I I . Klinische zowel als urody-
namische gegevens bij 85 patiënten, welke naar de uroloog werden ver-
wezen wegens mictieklachten na een prolapsoperatie, worden gepresen-
teerd. Van geen van de patiënten waren preoperatieve urodynamische 
gegevens beschikbaar. Ook was niet steeds te achterhalen wat de indicatie 
voor de voorwandplastiek was geweest, die soms was uitgevoerd in com-
binatie met een vaginale uterusextirpatie. In elk geval was echter duideli jk 
dat de patiënten hun mictieklachten of een verergering van reeds be-
bestaande mictieproblemen toeschreven aan de vaginale operatie. Echter, 
50 patiënten (59%) hadden reeds stress incontinentie op het ogenblik van 
de gynaecologische ingreep. In totaal werden 121 prolapsoperaties ver-
richt bij de 85 bestudeerde patiënten. Na uitgebreid urologisch en urody-
namisch onderzoek werden de volgende diagnoses gesteld: iatrogene of 
persisterende stress incontinentie (72%), sensorische urgency (48%), infra-
vesicale obstructie (40%), detrusorinstabiliteit (25%) en recidiverende 
cystit iden (24%). Een urogenitale fistel was aanwezig bij 5 patiënten en 
bij 2 vrouwen was een groot gedeelte van de urethra teloorgegaan. De 
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zogenaamde majeure complicaties, zoals urogenitale fistels, waren opera-
tief zeer goed te behandelen. De zogenaamde mineure complicaties, zo-
als sensorische urgency, outflow obstructie met of zonder incontinentie 
en recidiverende urineweginfecties, waren het moeilijkst te verhelpen en 
bleken vaak therapie-resistent. Ons na-onderzoek laat uiteraard niet toe 
de incidentie van deze urologische complicaties weer te geven. Uit het 
feit dat gemiddeld 1 patiente per week onze polikliniek bezoekt wegens 
dergelijke klachten, concluderen we echter dat deze complicaties vaker 
voorkomen dan over het algemeen wordt vermoed. Dit lijkt trouwens 
niet zo vreemd als men bedenkt dat ingrepen ter hoogte van de vagina-
voorwand, in het zeer delicate gebied van trigonum en blaashals, het 
sfinctermechanisme kunnen beschadigen en aanleiding kunnen geven tot 
postoperatieve (obstructieve) fibrose rondom de urethra. 
COMMENTAAR EN CONCLUSIES 
Met betrekking tot de medicamenteuze behandeling van de instabiele 
blaas wordt ingegaan op de vraag waarom zo weinig patiënten voldoende 
reageren. Zowel de etiologie als de pathofysiologie van de primaire of 
idiopathische instabiele blaas (waarbij geen organische oorzaak aantoon-
baar is) zijn nog steeds niet bekend. Er zijn geen duidelijke redenen om 
aan te nemen dat de idiopathische instabiele blaas het gevolg is van para-
sympathische overactiviteit. Het mag dan ook niet verwonderlijk zijn dat 
parasympathicolytische medicatie in vele gevallen geen effect zal hebben. 
Daarentegen is steeds duidelijker geworden dat urge incontinentie vaak 
een uiting is van psycho-emotionele labiliteit. Het feit dat een placebo 
even effectief kan zijn als een (actief) geneesmiddel steunt deze gedach-
tengang. Van vele courant gebruikte geneesmiddelen is overigens bekend 
dat zij na parenterale toediening niet steeds urodynamische veranderingen 
teweeg brengen (flavoxaat hydrochloride, Imipramine hydrochloride, 
emepronium bromide). Dat bromocriptine, een dopamine agonist, niet 
effectief is bij detrusorinstabiliteit, hebben inmiddels ook andere auteurs 
bewezen. Wel is door urodynamische evaluatie na intraveneuze toediening 
van een dopamine receptor antagonist (metoclopramide) de suggestie ge-
wekt dat dopamine receptoren helemaal niet belangrijk zouden zijn voor 
de functie van blaas en urethra. Over de klinische bruikbaarheid van in-
domethacine bij detrusorinstabiliteit zijn de laatste jaren geen publicaties 
meer verschenen. Men kan veronderstellen dat van dit geneesmiddel in-
derdaad geen heilzame werking, voor wat betreft blaasdysfuncties, moet 
verwacht worden. 
Het enthousiasme over de langdurige blaasdistentie is enigszins 
geluwd. Mededelingen in de literatuur over deze procedure blijken haast 
tot het verleden te behoren. Terloops zij vermeld, dat ook de blaastrans-
sectie, zeker wat onze ervaringen betreft, niet in staat is de blaas zodanig 
te denerveren dat een stabiele blaas wordt verkregen. Al met al is het 
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probleem van de onstabiele blaas nog steeds een groot probleem met 
een aanzienlijk aantal therapie-resistente gevallen 
Dat de mtravesicale prostaglandme-mstillatie bij chronisch residu 
van de vrouw met steeds een succesvolle behandeling is, b l i jk t ook uit re-
cente literatuurgegevens. Inmiddels is aangetoond dat vooral de gedener-
veerde blaas overgevoelig is voor intraveneus toegediend Prostaglandine 
Wellicht is danookal leen m geval van denervatiestoormssen van de blaas 
een respons te verwachten van mtravesicaal protaglandme 
De chirurgische behandeling van een uitgesproken cystocele (hetzij 
vaginaal, hetzij abdommaal) zal vooral afhangen van het feit of de ontsta-
ne implicaties van gynaecologische dan wel van urologische aard zi jn. In-
dien zich hoofdzakeli jk ontledigmgsstoornissen van de blaas manifeste-
ren, l i jkt de door ons beschreven transperitoneale co lpopromontono-
pexie een bevredigende oplossing Overigens is het nog zeer de vraag of 
een zeer grote cystocele alleen via vaginale weg voldoende kan gerepo-
neerd worden. 
Na een uitgebreide blaashalsmcisie (Prostatotomie) ¡η geval van 
beginnende of matige benige prostaathypertrofie kri jgt men weleens de 
indruk dat de vri jgekomen prostaatgedeelten m het lumen van de ure­
thra prolaberen en dat er aldus nog meer obstructie is ontstaan. Mede 
als gevolg van postoperatief oedeem kan een onbelemmerde mictie soms 
weken op zich laten wachten. Als regel stellen we dan ook dat liefst ge­
durende 2 maanden moet afgewacht worden vooraleer t o t blijvende m-
fravesicale obstrukt ie te besluiten en opnieuw m te gri jpen. Het aantal 
incisies beperken t o t één, m de veronderstelling dat hierdoor de kans op 
retrograde ejaculatie terugloopt, l i jkt met juist te z i jn. Het is logischer 
aan te nemen dat veeleer de lengte van de incisie (naar distaal) de bepa-
lende factor is voor het al dan met optreden van retrograde ejaculatie. 
BIJ de vrouw, en zeker m geval van acontracti l i teit van de detrusor, 
houdt de blaashalsmcisie het risico m van sfmcterinsufficientie met stress 
incontinentie. In dergelijke gevallen moet men zich dan ook terdege af-
vragen of deze procedure wel geïndiceerd is. 
Urine incontinentie tengevolge van geneesmiddelen zoals neuro-
leptica en antihypertensive, ontstaat meestal door interactie met de alfa-
receptoren m blaashals en proximale urethra Meerdere gevallen van 
urine incontinentie tijdens het gebruik van phenothiazmes en butyrophe-
nonen zijn beschreven Vooral bij vrouwen met een laag-normale urethra-
druk zal een antihypertensieve behandeling met guanethidme, prazosme 
of alfa-methyldopa gepaard gaan met stress incontinentie door verlaging 
van de mfravesicale weerstand Van deze ongewenste bi jwerking is inmid-
dels gebruik gemaakt bij de behandeling van patiënten met neurogene 
out f low obstructie en prostaatobstructie. Of ook ketanserm, als seroto-
nine antagonist met urethrarelaxerende eigenschappen, bruikbaar zal zijn 
bij out f low obstructie, moet nog worden onderzocht 
Dat vaginale voorwandplastieken oorzaak kunnen zi jn van mictie-
stoormssen is zeker onze ervaring. In de literatuur kunnen analoge erva-
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ringen echter niet worden teruggevonden. Mogelijk heeft dit te maken 
met het feit dat de patiënten uit gepubliceerde series geopereerd werden 
door eenzelfde team uiterst deskundige en technisch bedreven gynaeco-
logen. Het is ons althans duidelijk geworden dat de door ons geanaly-
seerde patiënten practisch steeds werden verwezen door eenzelfde be-
perkt aantal gynaecologen, terwijl wij van andere gynaecologen uit onze 
regio zelden patiënten kregen verwezen wegens urologische complicaties 
na een colporrhaphia anterior. 
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CURRICULUM VITAE 
De schrijver van dit proefschrift werd in 1947 te Kortrijk (België) geboren. 
Na zijn humaniora-studies aan het Sint Amandscollege te Kortrijk, stu-
deerde hij vanaf 1966 aan de Faculteit der Geneeskunde van de Katho-
lieke Universiteit te Leuven. In 1973 werd hij assistent op de afdeling 
Algemene Heelkunde van het Stedelijk Ziekenhuis te Roeselare (opleider: 
Dr. G.Cardoen). Vanaf 1-12-1975 was hij assistent op de afdeling Urolo-
gie van het Sint Radboud Ziekenhuis te Nijmegen (opleiders: Prof. Dr. 
W.A. Moonen, en later Prof. Dr. F.M.J. Debruyne). In de periode van 
1-1-1980 tot 1-3-1981 was hij als uroloog werkzaam in het Onze Lieve 
Vrouw Hospitaal te Kortrijk. Nadien keerde hij terug naar Nijmegen al-
waar hij werd aangesteld als wetenschappelijk medewerker op de afdeling 
Urologie. Vanaf 1-1-1983 is hij als uroloog gevestigd in het De Wever 
Ziekenhuis te Heerlen, het Sint Jozef Ziekenhuis te Kerkrade en het Sint 
Gregorius Ziekenhuis te Brunssum, in associatief verband met Dr. F.P.H. 
van de Weijer. 
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STELLINGEN 
behorende bij het proefschrift 
van K.P.J. Delaere 
SOME DYSFUNCTIONS A N D A B N O R M A L I T I E S OF THE 
LOWER U R I N A R Y TRACT 
CLINICAL AND URODYNAMIC ASPECTS 
De voorkeursbehandeling bij idiopathische detrusorinstabil iteit is nog 
steeds medicamenteus, ondanks het feit dat slechts in circa 30% der 
gevallen enig resultaat is te verwachten. 
II 
Het feit dat ketanserin de urethradruk verlaagt, pleit voor een zekere 
alfa-sympathicolytische activiteit van dit middel. 
Ill 
Het verdient aanbeveling bij vrouwen met incontinentia urinae dan wel 
met ontledigmgsstoornissen van de blaas, zo een operatieve behandeling 
is geïndiceerd, de blaashals zo veel mogelijk te ontzien. 
IV 
Vage onderbuiksklachten en dito mictieklachten worden al te vaak toe-
geschreven aan een cystocele. De diagnose 'cystocele' is een rekbaar 
begrip. 
V 
De urodynamica is over het paard geti ld. 
VI 
Bij vermeende galblaasziekten geniet het echografisch onderzoek van de 
galblaas de voorkeur als eerste onderzoek, boven het perorale contrast-
middelenonderzoek. 
(R.M.M, van Loenhout, P.T.J. Cremers, Ph.J. de Korte, 
J. Lens; Ned Tijdschr Geneeskd 1983, 127, 1951.) 
VII 
De behandeling van maldescensus testis dient voor het derde levensjaar 
te gebeuren. 
vin 
Wanneer voor de diagnostiek van pancreasaandoeningen de bepaling van 
het amylase-gehalte m urine wordt verricht, dient de verkregen waarde 
gerelateerd te worden aan het kreatinme-gehalte van hetzelfde urine-
monster, waardoor de sensitiviteit van de bepaling aanzienlijk toeneemt. 
IX 
Het succes van een orthopedische ingreep wordt evenzeer bepaald door 
de motivatie to t revalidatie van de patient, als door de deskundigheid 
van de chirurg. 
X 
BIJ de mult idiscipl inaire benadering van maligne urologische tumoren, 
dient de uroloog een centrale coördinerende rol te vervullen. 
XI 
De onmogeli jkheid to t herstel van een 'stroke' kan reeds m een zeer 
vroeg stadium van de ziekte worden bepaald door meting van de 'soma-
tosensory evoked potentials'. 
(proefschrift J W Vredeveld, in bewerking) 
XII 
Een Pseudomonas aeruginosa urineweginfectie moet aanleiding geven te 
denken dat de patient opgenomen is geweest m het ziekenhuis en waar-
schijnli jk onder handen is geweest van de uroloog. 
XIII 
In Nederlandse bierkringen gaat het verhaal dat bieren van hoge en lage 
gisting met onder één dak te brouwen zouden zijn vanwege wederzijdse 
onverdraagzaamheid der betrokken giststammen. Deze stelling schreeuwt 
om verwerping daar Belgische biei artiesten dit onmogeli jk geachte kunst-
stuk reeds lang volbrengen Het is verheugend, dat althans één wi t te raaf 
onder Nederlands brouwerijen voornemens is dit l ichtend voorbeeld te 
gaan volgen. 
XIV 
De enige echte overtuiging die een mens dient te hebben, is dat er mets 
te ernstig moet worden genomen. 
(Samuel Butler) 
Nijmegen, 22 november 1984. 



